---

Trigeminal Neuralgia

Note: The textbook library does not contain a "Piyush" oral medicine textbook (no such title is indexed). The content below is drawn from Bradley and Daroff's Neurology in Clinical Practice and Goldman-Cecil Medicine - both authoritative sources that cover trigeminal neuralgia in detail consistent with what oral medicine textbooks typically present.

---

Definition

• Goldman-Cecil Medicine, p. 1072

---

Epidemiology

• Incidence: ~4 per 100,000 individuals
• Most common between 50-70 years of age
• Slightly more common in women (1.5:1 female-to-male ratio)
• Begins after age 40 in 90% of patients
• Incidence progressively increases with age
• Rare familial cases have been described
• Bradley and Daroff's Neurology, p. 2497-2498

---

Classification (ICHD-3)

• Bradley and Daroff's Neurology, p. 2498

---

Pathogenesis & Etiology

• Classical TN is related to neurovascular compression of the trigeminal nerve by neighboring vessels:
  • Superior cerebellar artery (most common)
  • Anterior and posterior inferior cerebellar arteries
  • Superior petrosal vein
• Vascular compression increases with age and leads to focal demyelination of primary trigeminal afferents near the nerve root entry zone (at the pons)
• Demyelination leads to focal hyperexcitability and ectopic/repetitive neuronal discharges
• In younger patients: Multiple sclerosis is an important cause
• In older patients: Ectatic vertebrobasilar artery compression
• Bradley and Daroff's Neurology, p. 2498

---

Clinical Features

• Paroxysmal, electric shock-like, shooting, lancinating pain
• Lasts only seconds (up to 2 minutes per attack)
• May repeat at short intervals so attacks blur together
• After many attacks, a residual lingering facial pain may persist
• Usually unilateral

• V2 + V3 combination is the most common
• V2 (cheek/upper teeth) alone or V3 (chin/lower teeth) alone also common
• V1 (ophthalmic division) - extremely rare to be involved alone
• Pain during sleep is uncommon but can occur

• Most commonly near the nasolabial fold
• Trigger zone may be remote from the site of pain
• Common triggers: touching the face, chewing, teeth brushing, talking, swallowing, cool breeze striking the face

• Frequent attacks may cause weight loss, dehydration, or depression
• Goldman-Cecil Medicine, p. 1081; Bradley and Daroff's Neurology, p. 2497-2498

---

Physical Findings

• Classical TN: No sensory impairment; motor division of the nerve is intact
• Presence of sensory loss or masticatory muscle weakness suggests a secondary cause (more accurately called trigeminal neuropathy)
• Secondary causes to think about: lesion/mass affecting the gasserian ganglion, main sensory root, or root entry zone in the pons
• Bradley and Daroff's Neurology, p. 2498

---

Diagnosis

• Paroxysmal attacks of pain lasting seconds to 2 minutes
• Affects one or more divisions of the trigeminal nerve
• Pain is intensely sharp, stabbing, or precipitated by a trigger
• Each attack is stereotypical
• No other neurological deficits (in classical/idiopathic TN)

• MRI: Primary investigation - to look for structural lesions (pontine lacunar infarct, demyelinating plaque, meningioma, schwannoma, skull base malignancy)
• High-resolution MRI/MRA: May identify vascular compression
• EMG and blink reflex studies: Normal in idiopathic TN
• No accompanying laboratory or radiographic abnormalities in idiopathic TN

• Trigeminal autonomic cephalgia (has autonomic accompaniments)
• Atypical facial pain
• Idiopathic stabbing headache
• Tolosa-Hunt syndrome (inflammatory, anterior cavernous sinus)
• Glossopharyngeal neuralgia
• Goldman-Cecil Medicine, p. 1086; Bradley and Daroff's Neurology, p. 2498

---

Course & Prognosis

• Frequently exacerbating and remitting course over many years
• Spontaneous or medication-induced remissions are possible
• Microvascular decompression (MVD) can provide long-term relief

---

Treatment

Medical Management

• Carbamazepine side effects: vertigo, drowsiness, ataxia (especially if introduced quickly in elderly); agranulocytosis risk
• Monitoring: CBC, LFTs, serum sodium for first few months, then annually

Acute/Emergency Treatment

• IV fosphenytoin at 15-20 mg PE/kg for a patient in the midst of a severe attack
• Anesthetizing the ipsilateral conjunctival sac with proparacaine (topical ophthalmic anesthetic) - provides relief for several hours to days

Surgical Management

• Young, healthy patient refractory to medications: Posterior fossa MVD is the procedure of choice - longest pain relief, preserves sensation
• Elderly or medically compromised patient: Percutaneous procedures (radiofrequency thermocoagulation or balloon compression) are preferred
• Treatment must be individualized
• Bradley and Daroff's Neurology, p. 2498-2499; Goldman-Cecil Medicine, p. 1091

---

Summary Table

---

Regarding the "Piyush" textbook specifically: The medical library database does not contain any textbook by an author named "Piyush" or a standalone oral medicine title under that name. If you have a specific edition (e.g., "Textbook of Oral Medicine by Anil Govindrao Ghom" or similar), please let me know and I can refine the search. The content above covers trigeminal neuralgia comprehensively as it is presented in standard clinical textbooks.

---

BDS + MBA (IIM) - Salary & Career Options

---

Which IIMs Offer Relevant Programs?

For the flagship PGP (general MBA) at IIM-A/B/C/L, BDS holders are eligible via CAT and are evaluated like any other candidate. A BDS background is actually a differentiator in interviews for healthcare-related roles.

---

Salary Data from Official IIM Placement Reports (2024-2025)

IIM Jammu - MBA HA&HM (2024 Placement Report)

---

IIM Bodh Gaya - MBA-HHM (2025)

• 61 students placed out of 68 eligible
• Average CTC across all programs (including MBA): ₹14.96 LPA
• Highest: ₹48.58 LPA

---

IIM General PGP (if you get into IIMA/B/C via CAT)

---

Career Roles & Salaries for BDS + MBA

---

Key Sectors That Actively Hire BDS + MBA Graduates

1. Pharmaceuticals - Largest recruiter (31.8% of IIM HA&HM offers). Your clinical knowledge helps in medical affairs, regulatory, and field medical roles.
2. IT & Consulting - Healthcare digital transformation is booming. Companies like Cognizant, Carelon, Infosys Health hire heavily.
3. Medical Devices - Companies like Meril, J&J, Medtronic value clinical background for product and sales roles.
4. Hospital Chains - Apollo, Narayana, Fortis, Shalby for strategic/operations roles.
5. Health Insurance - Star Health, HDFC Life, Digit for product and claims roles.
6. Health-Tech Startups - Highest growth potential; equity + salary.

---

Realistic Salary Trajectory (BDS + IIM MBA)

---

Important Note on IIM Selection

• Specialist healthcare MBA (IIM Jammu HA&HM, IIM Bodh Gaya HHM): Easier admission, guaranteed healthcare placement network, avg ₹13-14 LPA.
• General IIM PGP (IIM-A/B/C via CAT): Very competitive, but opens doors to consulting, FMCG, tech - avg ₹30-35 LPA. Your BDS background becomes your interview differentiator for healthcare consulting roles at McKinsey, BCG, or Deloitte.

ST. JOSEPH DENTAL COLLEGE, ELURU

Oral Medicine and Radiology - II Internal Exam, IV BDS

Complete Answers to All 20 Questions

---

SECTION I: ESSAY QUESTIONS (2 × 9 = 18 marks)

---

Q1. Classify ulcerative and vesiculobullous lesions. Write in detail about history, clinical and oral manifestations, investigations, and management of Pemphigus Vulgaris.

---

A. CLASSIFICATION OF ULCERATIVE AND VESICULOBULLOUS LESIONS

ULCERATIVE LESIONS

• Mechanical (denture trauma, cheek bite)
• Chemical burns (aspirin burns, acid burns)
• Thermal burns

• Viral: Herpes simplex, Herpes zoster, Hand-foot-mouth disease
• Bacterial: Primary syphilis (chancre), Tuberculosis, Noma (cancrum oris)
• Fungal: Histoplasmosis, Mucormycosis

• Recurrent Aphthous Stomatitis (minor, major/Sutton's disease, herpetiform)
• Behcet's syndrome
• Reiter's syndrome
• Erythema multiforme
• Lichen planus (erosive type)

• Squamous cell carcinoma
• Salivary gland malignancies

• Blood dyscrasias (leukemia, agranulocytosis)
• Dermatological diseases (Pemphigus, Pemphigoid)
• Nutritional deficiencies

---

VESICULOBULLOUS LESIONS

• Herpes simplex virus (HSV-1, 2)
• Varicella zoster
• Hand, foot, and mouth disease
• Erythema multiforme
• Angina bullosa haemorrhagica

---

B. PEMPHIGUS VULGARIS (PV)

DEFINITION

• First described autoantibodies identified in 1964 by Beutner and Jordon.

---

HISTORY / EPIDEMIOLOGY

• Age: Most commonly fifth to sixth decade (40-60 years); oral lesions may precede skin lesions.
• Sex: Roughly equal male-to-female ratio, slight female predilection in some studies.
• Race/Ethnicity: Higher prevalence in Ashkenazi Jews and people of Mediterranean or Middle Eastern descent.
• Course: Chronic, relapsing - remitting. Prior to corticosteroids, mortality was nearly 100%.
• Onset: Oral lesions are the presenting sign in ~60-70% of patients and may precede skin lesions by an average of 5 months (up to 5 years in some cases).

---

CLINICAL MANIFESTATIONS

• Painful, irregular erosions and ulcers of the oral mucosa - the most common presenting sign
• Blisters are rarely seen intact in the mouth because they rupture readily, leaving behind ragged, bleeding erosions with overhanging epithelium
• Most commonly involved sites: buccal mucosa, palate, gingiva, tongue, lower lip
• Lesions are extremely painful, interfering with eating and drinking
• Positive Nikolsky's sign in the oral cavity - lateral pressure on apparently normal mucosa causes new blister formation
• Early lesions may appear as areas of desquamative gingivitis
• Oropharyngeal involvement seen in 87% of PV patients; nasal mucosa (76%), pharynx (66%), larynx (55%) also commonly affected

• Flaccid blisters (easily ruptured) on normal-looking or erythematous skin
• Blisters rupture to leave large painful erosions
• Common sites: scalp, face, axillae, groin, trunk
• Nikolsky's sign positive on skin: rubbing normal-appearing skin causes blister formation
• Asboe-Hansen sign (Bulla spread sign): pressure on intact blister causes lateral spread
• Healing with hyperpigmentation but no scarring in typical PV
• Pemphigus vegetans variant: exuberant granulation tissue (vegetations) in intertriginous areas (groin, axilla)

---

PATHOGENESIS

• Autoantibodies: IgG antibodies against Desmoglein 3 (mucosal type - oral lesions dominant) and Desmoglein 1 (mucocutaneous type - skin lesions added)
• Desmogleins are transmembrane cadherins found in desmosomes that maintain keratinocyte-to-keratinocyte adhesion
• Antibody binding leads to acantholysis (loss of cell-cell adhesion) and blister formation
• Suprabasal split - basal cells remain attached to the basement membrane like a "row of tombstones"
• Desmoglein compensation theory: Explains tissue specificity - oral mucosa expresses predominantly Dsg3, so anti-Dsg3 alone causes oral disease; skin expresses both Dsg1 and Dsg3, so both antibodies needed for skin blisters

---

INVESTIGATIONS

• Punch biopsy from the edge of a fresh lesion (perilesional tissue best)
• Shows: suprabasal acantholysis - cleft just above the basal layer
• "Tombstone appearance" - single row of basal cells remaining attached to basement membrane
• Acantholytic cells (Tzanck cells) in the blister cavity - round cells with large nuclei and prominent nucleoli

• Perilesional biopsy (4-6 mm punch) sent in Michel's transport medium
• Shows: IgG and C3 deposition in a fishnet/lace-like pattern throughout the epidermis (intercellular)
• Sensitivity ~90%

• Patient serum applied to monkey esophagus or normal human skin substrate
• Detects circulating anti-cell surface antibodies
• Titer correlates with disease activity

• Detects and quantifies anti-Desmoglein 1 and anti-Desmoglein 3 antibodies specifically
• Levels correlate with disease activity and can guide treatment
• Highly specific and sensitive

• Smear from base of fresh blister
• Shows Tzanck cells (acantholytic cells) - round cells with large vesicular nucleus
• Rapid but not specific (also positive in herpes)

• CBC, blood glucose, serum electrolytes (baseline before steroids)
• Chest X-ray (to rule out infections before immunosuppression)
• Serum albumin (nutritional status)

---

MANAGEMENT

• Prednisolone: 1 mg/kg/day orally (60-100 mg/day)
• Dexamethasone cyclophosphamide pulse (DCP pulse): 100 mg dexamethasone IV over 3 days monthly + oral cyclophosphamide 50 mg/day

• Azathioprine (1.5-2.5 mg/kg/day) - most commonly used adjuvant
• Mycophenolate mofetil (2-3 g/day) - good alternative with less hepatotoxicity
• Cyclophosphamide - for refractory cases
• Methotrexate - for mild-moderate disease

• Targets CD20+ B lymphocytes (depletes autoreactive B cells)
• 375 mg/m² IV weekly × 4 doses (lymphoma protocol) OR
• 1000 mg IV × 2 doses (rheumatoid arthritis protocol, 2 weeks apart)
• Now considered first-line along with corticosteroids for moderate-to-severe disease
• High remission rates; may allow steroid tapering

• 2 g/kg per cycle over 3-5 days
• Rapidly reduces pathogenic antibody levels
• Used for severe, refractory, or flaring disease

• Removes circulating autoantibodies rapidly
• Used in acute severe disease

• Triamcinolone acetonide 0.1% in Orabase - for localized oral erosions
• Chlorhexidine mouth rinses (0.12-0.2%) - prevent secondary infection
• Viscous lidocaine for pain relief before meals
• Soft, non-irritating diet

• Anti-Dsg3/Dsg1 ELISA titers to monitor response
• Regular blood counts, liver and kidney function
• Bone density (long-term steroid use)
• Blood glucose monitoring

---

---

Q2. Write in detail about X-ray tube head with a neat labelled diagram. Write about production of X-rays.

---

X-RAY TUBE HEAD

---

COMPONENTS OF THE X-RAY TUBEHEAD

• Made of aluminium or steel
• Lead-lined to prevent radiation leakage
• Filled with insulating oil (transformer oil) for cooling and electrical insulation

• Contains the filament (made of tungsten wire, coiled)
• Filament is enclosed in a focusing cup (molybdenum)
• When current passes through the filament, it heats up and releases electrons by thermionic emission (Edison effect)
• The focusing cup directs the electron beam towards the anode
• Tube current (mA) controls the number of electrons (quantity of X-rays)

• Contains the target - a small tungsten block embedded in a copper stem
• Tungsten is used because: high atomic number (74), high melting point (3422°C), high density, good thermal conductivity
• Focal spot: Small area on the anode where electrons strike and X-rays are produced
• Target angle (anode angle): 6-20° - determines effective focal spot size
• Copper dissipates heat generated during X-ray production
• Stationary anode used in dental X-ray tubes (rotating anodes in medical CT)

• High vacuum maintained inside
• Allows electrons to travel without collision

• Placed in the path of the X-ray beam
• Function: Removes low-energy (soft, long wavelength) X-rays that would be absorbed by patient tissues without contributing to the image
• Thickness: 1.5 mm (for <70 kVp) or 2.5 mm (for ≥70 kVp) as per regulations
• Increases mean photon energy of the beam (beam hardening)

• A lead disc or plate with a central aperture
• Function: Restricts and shapes the X-ray beam to the required field size
• Reduces patient radiation dose by limiting the area irradiated
• Types: Circular, rectangular (rectangular collimation reduces dose significantly)

• Extends from the collimator to the patient's face
• Functions: Indicates where to position the X-ray beam; establishes source-to-skin distance; shapes the beam
• Types: Round/circular cone, Rectangular PID (RINN type)
• Open-ended cylinders preferred over pointed cones (pointed cones scatter more)

• Step-up (high voltage) transformer: Increases voltage to 60-90 kVp needed to accelerate electrons
• Step-down (low voltage) transformer: Provides low voltage (3-10V) to heat the filament
• kVp (kilovoltage peak) controls the energy/penetrating power of X-rays (quality of beam)

• An aluminium or leaded glass port window through which the X-ray beam exits
• The rest of the tubehead is heavily shielded

---

DIAGRAM OF X-RAY TUBEHEAD

         TUBEHEAD HOUSING (Lead-lined metal)
    ┌─────────────────────────────────────────┐
    │   [TRANSFORMER ASSEMBLY]                │
    │                                         │
    │    X-RAY TUBE (Vacuum glass envelope)   │
    │  ┌──────────────────────────────────┐   │
    │  │  CATHODE          ANODE          │   │
    │  │  [Filament]───e⁻→[Target/Focal  │   │
    │  │  [Focusing cup]    spot]         │   │
    │  │                  (Tungsten on Cu)│   │
    │  └──────────────────────────────────┘   │
    │         ↓ X-rays produced               │
    │   [ALUMINIUM FILTER]  (beam hardening)  │
    │         ↓                               │
    │   [LEAD COLLIMATOR]  (beam restriction) │
    └──────────────────────────┬──────────────┘
                               ↓
                    [POSITION INDICATING DEVICE]
                               ↓
                          PATIENT

---

PRODUCTION OF X-RAYS

---

Mechanism 1: BREMSSTRAHLUNG RADIATION (Braking Radiation)

• Accounts for ~70-80% of the X-ray output in dental radiography
• Electrons from the cathode travel at high speed toward the anode
• An electron passes close to the nucleus of a tungsten atom
• The positively charged nucleus attracts the electron, causing it to decelerate and change direction
• The kinetic energy lost during deceleration is released as an X-ray photon
• Energy of the photon = energy lost by the electron
• Electrons losing varying amounts of energy produce X-rays of varying wavelengths (polychromatic beam)
• An electron can lose all its energy in one interaction (maximum energy = kVp) producing the shortest wavelength X-ray

---

Mechanism 2: CHARACTERISTIC RADIATION

• Accounts for ~20-30% of the X-ray output
• A high-speed electron strikes and ejects an inner shell electron (e.g., K-shell) of the tungsten atom
• This creates a vacancy (electron hole) in the inner shell
• An outer shell electron drops inward to fill the vacancy
• This transition releases energy as an X-ray photon of specific, characteristic energy
• The photon energy = difference in binding energies between the two shells

---

FACTORS CONTROLLING X-RAY PRODUCTION

---

PROPERTIES OF X-RAYS

1. Invisible, travel at speed of light (3×10⁸ m/s)
2. Travel in straight lines (cannot be focused by lenses)
3. Polyenergetic (polychromatic) beam from dental tubes
4. Cause ionization of matter
5. Cause fluorescence of certain substances
6. Can expose photographic film
7. Penetrate matter (degree depends on atomic number and density of object)
8. Biological effects: cell damage, mutation, carcinogenesis

---

---

SECTION II: SHORT ANSWER QUESTIONS (8 × 4 = 32 marks)

---

Q3. Oral Manifestations of Diabetes Mellitus. Write about Oral Glucose Tolerance Test.

ORAL MANIFESTATIONS OF DIABETES MELLITUS

• Most significant and well-established oral manifestation
• Diabetes is a major risk factor for periodontitis (bidirectional relationship)
• Rapidly progressive, severe periodontitis even in young patients
• Reduced neutrophil chemotaxis, impaired healing, altered collagen metabolism
• Poor glycemic control worsens periodontitis; treating periodontitis can improve HbA1c

• Reduced salivary flow (hyposalivation)
• Due to dehydration, autonomic neuropathy affecting salivary glands, polyuria
• Leads to: difficulty chewing/swallowing, altered taste, halitosis

• Increased salivary glucose concentration
• Altered salivary pH (more acidic)
• Reduced salivary IgA
• Parotid gland enlargement (sialadenosis/sialosis) due to fatty infiltration

• Very common - elevated salivary glucose promotes Candida overgrowth
• Presentations: pseudomembranous candidiasis, erythematous candidiasis, angular cheilitis, denture stomatitis
• Particularly common in denture wearers

• Burning sensation of tongue and oral mucosa
• Associated with neuropathy, xerostomia, candidiasis

• Ageusia/dysgeusia due to neuropathy and xerostomia

• Increased caries risk due to xerostomia, elevated salivary glucose, reduced buffering capacity
• Reduced salivary flow decreases self-cleansing

• Post-extraction sockets heal slowly
• Increased risk of dry socket (alveolar osteitis)
• Increased risk of infections following dental procedures

• Higher prevalence of erosive lichen planus in diabetics

• In uncontrolled or ketoacidotic diabetes

• Facial pain, burning, paresthesia

---

ORAL GLUCOSE TOLERANCE TEST (OGTT)

• Screening for diabetes mellitus, pre-diabetes, and gestational diabetes
• When fasting glucose is borderline (6.1-6.9 mmol/L)
• Diagnosis of impaired glucose tolerance
• Relevant in oral medicine - used when diabetic background is suspected in a patient with severe periodontitis, repeated candidiasis, poor healing

• 3 days of unrestricted carbohydrate diet (>150g/day)
• Fast for 8-14 hours overnight (water permitted)
• No exercise, smoking, or medication on test morning
• Test performed in the morning

1. Fasting blood glucose measured (baseline)
2. Patient drinks 75g anhydrous glucose dissolved in 250-300 mL water (over 5 minutes)
3. For gestational diabetes: 100g glucose load
4. Blood glucose measured at 1 hour and 2 hours post-load
5. (In some protocols: 30, 60, 90, 120 minutes)

---

Q4. Drug-Induced Gingival Enlargement

CAUSATIVE DRUGS (Three main categories):

PATHOGENESIS:

• These drugs affect calcium ion channels in gingival fibroblasts
• Leads to decreased collagen degradation (reduced collagenase activity)
• Results in accumulation of collagen in the connective tissue
• Poor oral hygiene and plaque worsen the enlargement
• Genetic susceptibility plays a role (HLA typing)
• Direct drug action on gingival fibroblasts → increased fibroblastic proliferation and collagen synthesis

CLINICAL FEATURES:

• Begins as painless, firm enlargement of the interdental papillae
• Progresses to cover the crowns of teeth (may obscure them completely)
• Typically starts in the anterior teeth (especially maxillary and mandibular incisors)
• Enlargement is diffuse, lobulated, and pink (firmer than inflammatory tissue)
• Bleeds on probing if secondary inflammation is present
• Edentulous areas are NOT affected (drug effect requires tooth/plaque)
• Phenytoin: firm, fibrous, pale pink tissue; not dependent on plaque
• Cyclosporine: more vascular, softer, more hemorrhagic
• Nifedipine: similar to phenytoin but less dense

HISTOPATHOLOGY:

• Hyperplastic stratified squamous epithelium with elongated rete ridges
• Dense fibrous connective tissue with abundant collagen bundles
• Increased fibroblasts
• Variable inflammatory infiltrate depending on oral hygiene

MANAGEMENT:

1. Drug substitution: Replace offending drug if medically feasible (e.g., phenytoin → valproate; nifedipine → amlodipine → then another class)
2. Improved oral hygiene: Scaling, root planing, professional cleaning - often causes regression in mild cases
3. Chlorhexidine rinses (0.2%): Reduce plaque and inflammation
4. Surgical removal: Gingivectomy or periodontal flap surgery for severe cases
5. Folic acid supplementation (reduces phenytoin-induced enlargement)
6. Prevention: Baseline dental review before starting these drugs; meticulous oral hygiene throughout

---

Q5. Bite Marks

DEFINITION:

CLASSIFICATION:

1. Inhibited bite - Tooth contact but no break in skin
2. Contusion - Hemorrhage/bruising without skin break
3. Abrasion - Superficial scraping of skin
4. Laceration - Tearing of skin
5. Incision - Clean cut through skin
6. Avulsion - Tissue torn away

• Human bite marks: Oval/elliptical, paired arches (maxillary and mandibular), ~4-5 cm in greatest dimension
• Animal bite marks: Usually show single deep puncture wounds from canines, often with tissue avulsion

SITES IN ASSAULT/ABUSE CASES:

• Breast, shoulder, upper arm, thigh, buttocks (sexual assault)
• Cheeks, neck (child abuse)
• Defensive bite marks: knuckles, hands

CHARACTERISTICS OF HUMAN BITE MARK:

• Two opposing arched patterns (U-shaped)
• Each arch ~2-3 cm in radius
• Shows individual tooth marks within the arches
• Maxillary: broader, more rounded
• Mandibular: narrower, more square
• May show suck marks (central area of bruising) in sexual assault

FORENSIC ANALYSIS:

1. Documentation: Photography (standard scale, UV photography, 3D imaging)
2. Swabbing: DNA from saliva on bite mark (within 24-48 hours)
3. Impression: Bite mark cast
4. Comparison: Dental stone models of suspect's teeth compared with bite mark patterns
5. Overlay method: Transparent overlay of suspect's dental arch compared to bite mark

SIGNIFICANCE IN ORAL MEDICINE:

• Bite marks may present as traumatic ulcers (self-inflicted biting in seizures, or habitual cheek biting)
• Morsicatio buccarum (cheek biting): White, irregular, shredded appearance of buccal mucosa
• Must be differentiated from leukoplakia and other white lesions

---

Q6. What is a Grid? Write in Detail About Types of Grids.

DEFINITION:

WHY IS A GRID NEEDED?

• When X-rays interact with tissue, Compton scattering produces scattered photons that travel in all directions
• These scattered photons expose the film non-selectively, causing fog (uniform grey density), which reduces contrast
• Grids preferentially transmit the primary (useful) beam while absorbing scattered rays

GRID CONSTRUCTION:

• Composed of alternating strips of:
  • Lead (radiopaque strips): Absorb scattered radiation
  • Interspacer material (radiolucent): Aluminium, plastic, or carbon fiber - allows primary X-rays to pass
• The lead strips are oriented so the primary beam can pass through the radiolucent interspaces

GRID RATIO:

• Grid ratio = height of lead strip (h) ÷ width of interspace (D)
• Higher grid ratio = more efficient scatter removal but more primary radiation absorbed
• Common ratios: 5:1, 6:1, 8:1, 10:1, 12:1, 16:1
• Higher ratio grids require precise alignment (more critical)

GRID FREQUENCY:

• Number of lead strips per cm or inch
• Typical: 25-45 lines/cm
• Higher frequency = less grid lines visible on film

---

TYPES OF GRIDS

A. Based on Lead Strip Orientation:

• Lead strips are all parallel to each other and perpendicular to the film surface
• Simple construction
• Disadvantage: grid cut-off at periphery (edges of image cut off) because peripheral primary rays are angled and absorbed by grid
• Used for large-field radiography

• Two linear grids placed at right angles to each other
• More efficient scatter removal
• Requires very precise alignment; cannot be angled
• Not commonly used

• Lead strips are angled to match the divergence of the primary X-ray beam
• Strips converge toward a point called the convergence point or focal distance
• Must be used at the specific focal distance for which it was designed
• More efficient than parallel grids; no peripheral cut-off
• Most commonly used in diagnostic radiology

• A compromise between focused and parallel grid
• Strips angled at the periphery only

B. Based on Motion:

• Fixed in position during exposure
• Grid lines may be visible on the radiograph (grid lines artifact)
• Used in portable or low-volume settings

• Grid moves during exposure (oscillates or reciprocates)
• Blurs out the grid lines so they are not visible on the final radiograph
• Invented by Gustav Bucky (1913) and improved by Hollis Potter
• Bucky grid refers to the moving grid mechanism incorporated into the radiographic table/upright stand
• Standard in medical radiography
• Cannot be used for very short exposures (grid may not complete its movement)

C. Based on Interspacing Material:

• Spaces between lead strips filled with aluminium
• Durable, commonly used

• Carbon fiber interspacer
• Lower absorption of primary beam → lower patient dose
• Used in mammography

• Not an actual grid; the air space between the patient and the film acts as natural scatter rejection
• Useful when physical grid is not available

---

GRID PERFORMANCE MEASURES:

• Bucky factor (B): The factor by which patient exposure must be increased to compensate for X-rays absorbed by the grid (typically 2-6×)
• Contrast improvement factor (K): Ratio of contrast with grid to contrast without grid (measures grid efficiency)
• Selectivity (Σ): Ratio of primary radiation transmitted to scatter transmitted

GRIDS IN DENTAL RADIOLOGY:

• Rarely used in intraoral dental radiography (small field, lower scatter)
• Used in cephalometric and panoramic radiography (larger fields)
• Digital sensors have somewhat reduced the need for grids due to better contrast resolution

---

Q7. Oral Manifestations of Vitamin B Deficiency

• Angular cheilitis (cracks at corners of mouth): B2, B6, B12, iron deficiency, riboflavin deficiency
• Glossitis is common to almost all B vitamin deficiencies
• Hunter's/Moeller's glossitis: smooth, depapillated, erythematous tongue - B12 and folate deficiency
• Combined B12/folate deficiency → macrocytic megaloblastic anemia → pallor of oral mucosa

---

Q8. Dosimetry - Write in Detail About Types of Dosimeters

DEFINITION:

IMPORTANCE IN DENTISTRY:

• Monitors occupational radiation exposure of dental personnel
• Ensures compliance with maximum permissible dose (MPD) limits
• Legal requirement in most countries for radiation workers

---

TYPES OF DOSIMETERS

1. FILM BADGE DOSIMETER (Photographic Film Dosimeter)

• Most widely used for personnel monitoring
• Contains a small piece of dental/X-ray film in a plastic badge holder
• The badge has filters of different materials (aluminium, copper, tin, lead) at different positions
• Radiation darkens the film - optical density measured by densitometer
• Measures: X-rays, gamma rays, beta, neutrons (with different filters)
• Advantages: Permanent record, measures dose equivalent, inexpensive, reliable
• Disadvantages: Must be sent to laboratory for processing; not real-time; humidity/heat can affect it
• Worn: On chest, collar, or wrist; changed monthly
• Not worn: During dental radiography itself (it should be left at the operatory)

2. THERMOLUMINESCENT DOSIMETER (TLD)

• Contains thermoluminescent material: LiF (lithium fluoride), CaF₂, Li₂B₄O₇
• When exposed to radiation, electrons get trapped in crystal lattice energy states
• On heating (to ~220°C), trapped electrons release energy as visible light
• Amount of light = proportional to radiation dose (measured by photomultiplier)
• Advantages: Highly accurate, can be reused, small size, reads low doses, not affected by humidity, measures wide range of doses, most accurate for X-ray doses
• Disadvantages: Cannot be re-read; requires special reader; no permanent record after reading
• Gold standard for accurate dose measurement in radiation protection research
• Available as chips, rings, finger badges

3. POCKET DOSIMETER (Ionization Chamber / Pen Dosimeter)

• A direct-reading ionization chamber shaped like a fountain pen
• Contains a charged quartz fiber on a scale visible through a lens
• Ionizing radiation discharges the capacitor → fiber deflects
• Dose read directly by looking through the eyepiece
• Types:
  • Self-reading (can be read by wearer at any time)
  • Non-self-reading (requires external reader)
• Advantages: Immediate, direct reading; portable; no laboratory processing
• Disadvantages: Can discharge spontaneously (false high reading), fragile, expensive per unit, no permanent record
• Used in emergency/accident situations for real-time monitoring

4. ELECTRONIC PERSONAL DOSIMETER (EPD) / ACTIVE DOSIMETER

• Modern digital electronic device using silicon diodes or mini-ionization chambers
• Provides real-time digital display of current dose rate and cumulative dose
• Alarms can be set at dose thresholds
• Can be read instantly; data can be stored and transmitted electronically
• Advantages: Real-time reading, alarm capability, data logging, rechargeable
• Disadvantages: Expensive, can be affected by high-dose rate fields

5. OPTICALLY STIMULATED LUMINESCENCE (OSL) DOSIMETER

• Similar principle to TLD but uses laser light (not heat) to stimulate light emission
• Material: Aluminum oxide (Al₂O₃:C)
• Can be re-read multiple times (unlike TLD)
• Accurate for low doses, wide dose range
• Currently replacing film badges in many countries

6. GEIGER-MULLER (GM) COUNTER

• Not a personal dosimeter but a survey meter for area monitoring
• Cylindrical gas-filled tube; radiation ionizes the gas causing a current pulse counted as "clicks"
• Sensitive to low levels; gives real-time area dose rate
• Used for contamination surveys, not personal dosimetry

---

MAXIMUM PERMISSIBLE DOSE (MPD) / DOSE LIMITS (ICRP recommendations):

• Radiation workers: 20 mSv/year (averaged over 5 years); never exceeding 50 mSv in any single year
• Pregnant radiation workers: 1 mSv for the remainder of pregnancy
• General public: 1 mSv/year

---

Q9. Warthin's Tumor

DEFINITION:

EPIDEMIOLOGY:

• Accounts for approximately 10% of all parotid tumors
• Male preponderance (3-4:1 male-to-female; though ratio is narrowing as more women smoke)
• Most commonly occurs in fifth to seventh decade (50-70 years)
• Strongly associated with cigarette smoking (smokers have 8× higher risk)
• More prevalent in Caucasians
• Bilateral in 10% of cases (unique among salivary gland tumors) - occasionally multifocal

ETIOLOGY/PATHOGENESIS:

• Arises from ectopic salivary gland tissue entrapped in periparotid or intraparotid lymph nodes during embryogenesis
• The ductal epithelium undergoes oncocytic metaplasia and proliferates within lymphoid stroma
• Not truly a neoplasm by some definitions - may represent a developmental anomaly/hamartoma

CLINICAL FEATURES:

• Location: Exclusively in the parotid gland, usually in the tail of the parotid (posterior inferior parotid)
• Presents as a soft, cystic, compressible or fluctuant swelling
• Painless, slow-growing mass
• May have periodic variation in size (due to cystic nature with drainage)
• Skin overlying it is normal and mobile over the tumor
• Facial nerve function is normal
• Bilateral in 10% of cases - an important diagnostic clue
• Rarely undergoes malignant transformation (<1%)

HISTOPATHOLOGY:

• Inner layer: tall columnar oncocytic cells with granular eosinophilic cytoplasm (mitochondria-rich)
• Outer layer: small cuboidal/basal cells
• Epithelium forms papillary projections into cystic spaces filled with mucoid/serous material
• Prominent lymphoid stroma with germinal centers surrounding the cystic structures
• The combination of oncocytic epithelium + lymphoid stroma is pathognomonic

INVESTIGATIONS:

• FNA cytology (Fine Needle Aspiration): Shows oncocytes and lymphocytes - diagnostic
• Ultrasound: Well-circumscribed, hypoechoic, cystic mass
• CT/MRI: Well-defined, multilocular, cystic lesion in parotid tail
• Technetium-99m pertechnetate scan: Hot spot (increased uptake) - characteristic due to mitochondria-rich oncocytic cells; one of the few salivary gland tumors showing a hot spot

MANAGEMENT:

• Surgical excision - superficial parotidectomy with facial nerve preservation
• Low recurrence rate after complete excision
• Malignant transformation is extremely rare (<1%)

---

Q10. Write in Detail About Hyperparathyroidism

DEFINITION:

CLASSIFICATION:

• Autonomous PTH overproduction from the parathyroid gland itself
• Causes: Single adenoma (85%), hyperplasia (all 4 glands, 10-15%), carcinoma (<1%), MEN syndromes

• Compensatory PTH overproduction in response to chronic hypocalcemia
• Causes: Chronic kidney disease (most common), vitamin D deficiency, malabsorption, osteoporosis

• Autonomous PTH secretion developing from longstanding secondary hyperparathyroidism (even after the original stimulus is removed - e.g., after renal transplant)

---

GENERAL MANIFESTATIONS ("Bones, Stones, Groans, Moans"):

• Bones: Bone pain, pathological fractures, osteitis fibrosa cystica
• Stones: Renal calculi (nephrolithiasis) from hypercalciuria
• Groans: Abdominal pain, nausea, vomiting, constipation, pancreatitis, peptic ulcer
• Moans: Neuropsychiatric symptoms (depression, anxiety, cognitive impairment, weakness)

---

ORAL AND MAXILLOFACIAL MANIFESTATIONS

• Classic skeletal manifestation of severe/longstanding hyperparathyroidism
• PTH causes osteoclastic resorption → replacement of bone by fibrous tissue
• Jaw involvement: Loss of cortical bone, thinning of cortex

• Not true tumors - collections of osteoclasts, fibrous tissue, and hemorrhagic/hemosiderin-containing foci
• Brown color due to hemosiderin deposits
• Appear as well-defined radiolucent lesions in the jaws (and other bones)
• Can cause cortical expansion, pathological fractures
• Can occur in both primary and secondary hyperparathyroidism
• On biopsy: indistinguishable from giant cell granuloma - clinical/biochemical correlation needed

• Brown tumors histologically identical to central giant cell granuloma

• Loss of lamina dura around teeth (classic sign - normally a dense white line around roots)
• Ground-glass appearance of bone (loss of normal trabecular pattern)
• Subperiosteal bone resorption on radial aspect of middle phalanges (classic)
• Generalized osteopenia/osteoporosis of jaws
• "Salt and pepper" skull: Mixed lytic and sclerotic areas on skull radiograph
• Brown tumors appearing as well-defined unilocular or multilocular radiolucencies

• Tooth mobility (loss of supporting bone)
• Malocclusion (jaw expansion by lesions)
• Delayed eruption

• Ectopic calcification, metastatic calcification of soft tissues
• Sialolithiasis (salivary gland stones) - may be seen in chronic hypercalcemia

---

DIAGNOSIS:

• Serum calcium: elevated (>10.5 mg/dL in PHP)
• Serum PTH: elevated (key)
• Serum phosphate: low
• Urinary calcium: elevated
• ALP: elevated (bone isoenzyme)
• Imaging: DEXA scan (bone density), renal ultrasound, Tc-99m sestamibi scan (localizes adenoma)

MANAGEMENT:

• Primary: Surgical parathyroidectomy for symptomatic or high-risk patients
• Medical management for asymptomatic mild PHP: bisphosphonates, cinacalcet (calcimimetic)
• Brown tumors often regress spontaneously after PTH levels normalize post-surgery
• Secondary: treat underlying cause (CKD management, vitamin D supplementation, phosphate binders, cinacalcet)

---

---

SECTION III: VERY SHORT ANSWERS (10 × 2 = 20 marks)

---

Q11. Cervical Burnout

• Definition: A radiographic artifact that produces a false appearance of a carious lesion (radiolucency) at the cervical region of a tooth, where it narrows just below the contact point.
• Cause: The cervical region of the tooth has a reduced cross-sectional area (narrowing at the neck of the tooth), so fewer X-rays are absorbed here compared to the crown and root. This differential absorption creates an apparent radiolucency.
• The interproximal geometry at the cementoenamel junction creates a zone where the beam passes through less tooth structure.
• Clinical significance: Can be mistakenly diagnosed as cervical caries.
• Differentiation from true caries: Burnout appears consistently in the same location on every radiograph; it has smooth, regular borders; there is no cavitation visible clinically; explorer does not catch; the radiolucency disappears on different angulations.
• Prevention: Using the long-cone paralleling technique reduces cervical burnout compared to bisecting angle technique.

---

Q12. Tyre Track Effect

• Also called the "streetcar track" or "rail track" sign in dental radiology.
• Description: Bilateral radiopaque lines (stripes) running along the inner surface of the buccal cortical bone of the mandible, separated by a radiolucent stripe in between - resembling tram/tyre tracks.
• Cause: Calcification within the temporalis tendon insertion or the buccinators/buccal fat pad; however, more specifically it describes the appearance of the buccal cortex and the mylohyoid ridge or the mental foramen area producing parallel lines.
• In some contexts, tyre track effect refers to the parallel radiopaque lines seen due to the cortical plates of the mandible on panoramic/occlusal views.
• Clinical significance: A normal anatomical variant; should not be confused with pathology.
• Can also be seen in conditions causing subperiosteal new bone formation (periosteal reaction) where parallel layers of bone are laid down, producing a "onion skin" or tyre track appearance - associated with Ewing's sarcoma or osteomyelitis.

---

Q13. Radiographic Features of Periapical Cyst and Periapical Granuloma

Periapical Granuloma:

• Radiolucency at the apex of a non-vital tooth
• Usually small (< 1 cm in diameter)
• Well-defined but not necessarily corticated margin
• Round or oval radiolucency
• Continuous with the widening of periodontal ligament space
• Loss of lamina dura at the apex
• Cannot be reliably distinguished from a cyst radiographically - histology needed

Periapical Cyst (Radicular Cyst):

• Radiolucency at the apex of a non-vital tooth (same as granuloma)
• Usually larger (>1 cm, may reach several cm)
• Well-defined, corticated (sclerotic white border) radiolucency - due to reactive bone formation
• Round to ovoid shape
• May cause displacement of adjacent teeth and resorption of adjacent tooth roots
• May expand the cortical plates
• Continuous with the periodontal ligament space

Key Differences:

---

Q14. Café-au-Lait Spots

• Definition: Light brown ("coffee-with-milk" colored) macules (flat pigmented lesions) on the skin, varying in shade from light tan to dark brown.
• Size: Variable, from a few mm to several cm.
• Borders: Smooth, regular margins ("Coast of California" smooth border) in NF1; irregular ("Coast of Maine") in McCune-Albright.
• Significance:
  • Neurofibromatosis Type 1 (NF-1 / von Recklinghausen's disease): ≥6 café-au-lait spots (>5mm prepubertal, >15mm postpubertal) = diagnostic criterion; associated with neurofibromas, Lisch nodules, bone lesions, optic gliomas
  • McCune-Albright Syndrome: Large café-au-lait spots + polyostotic fibrous dysplasia + precocious puberty
  • Other conditions: Fanconi anemia, tuberous sclerosis, Gaucher disease, normal population (1-3 spots common in normal individuals)
• Oral/Dental relevance: NF-1 can cause oral neurofibromas, mandibular enlargement, widened inferior alveolar canal, absent or abnormal coronoid/condylar processes on OPG; fibrous dysplasia affects the jaws causing unilateral facial asymmetry.

---

Q15. White Sponge Nevus

• Also called: Cannon's disease, White Folded Gingivostomatitis.
• Nature: A hereditary, benign condition; autosomal dominant inheritance.
• Genetics: Mutations in keratin 4 (KRT4) or keratin 13 (KRT13) genes, which encode cytokeratins found in non-keratinized (lining) oral mucosa.
• Clinical Features:
  • Bilateral, symmetrical, white, folded/spongy, thickened plaques on the oral mucosa
  • Buccal mucosa is most commonly affected bilaterally (always bilateral and symmetric)
  • Lesions have a rough, corrugated, velvety texture
  • Painless, does not rub off (unlike candidiasis)
  • Present since childhood/birth; may fluctuate slightly
  • Can involve labial mucosa, floor of mouth, tongue
  • Other mucosal sites: nasal, esophageal, vaginal, rectal mucosa also affected
• Histopathology: Thick parakeratotic epithelium, extensive intraepithelial edema (vacuolization of spinous layer), basket-weave appearance of superficial keratinocytes, nuclear pyknosis with perinuclear eosinophilic condensation.
• No malignant potential
• Management: Reassurance; no treatment needed; tetracycline mouthwash may reduce thickness in some cases; genetic counseling.

---

Q16. Auspitz Sign

• Definition: A clinical sign in which gentle scraping of a scaly skin lesion (psoriatic plaque) with a wooden spatula or curette produces pinpoint bleeding from the dermal papillae after the scales are removed.
• Why it occurs: Psoriasis causes thinning of the suprapapillary epidermis over elongated dermal papillae (due to parakeratosis and acanthosis). Removing the scales first removes the overlying corneal layer, then the thin suprapapillary plate, exposing the dilated capillary loops in the dermal papillae which bleed as pinpoint red dots.
• Sign of: Psoriasis - highly characteristic.
• Significance in oral medicine: Psoriasis can have oral manifestations (geographic tongue/migratory glossitis is more common in psoriatic patients; rarely, psoriatic plaques on the oral mucosa); Auspitz sign is elicited on skin lesions to aid diagnosis, which then alerts the clinician to look for oral involvement.
• Auspitz sign is not present in seborrheic dermatitis (main differential of psoriasis) - important distinguishing point.

---

Q17. Antrolith and Phlebolith

ANTROLITH:

• A calcified mass (calculus) within the maxillary sinus (antrum).
• Also called rhinolith when in the nasal cavity.
• Formed by calcification around a foreign body (tooth, dental material, inspissated mucus) or de novo around a mucous plug.
• Radiographic features: Radiopaque mass within the maxillary sinus on OPG or Waters' view; may have a laminated structure.
• Symptoms: Facial pain, nasal discharge, sinusitis if large.

PHLEBOLITH:

• A calcified thrombus within a vein or vascular malformation (especially venous hemangioma).
• "Phlebos" = vein; "lithos" = stone.
• Results from dystrophic calcification of a thrombus that underwent organization.
• Radiographic features: Multiple small, round to oval radiopaque foci with a concentric laminated (onion-skin) pattern - pathognomonic.
• Typically seen in the cheek region in panoramic/lateral views, associated with venous malformations or haemangiomas.
• Location: Commonly in the masseter or buccinator region, floor of mouth, orbit, abdomen.
• Significance: Presence of phleboliths in the head and neck strongly suggests a venous malformation (low-flow vascular malformation).
• Not harmful in themselves; the underlying vascular lesion requires treatment if symptomatic.
• Differentiation: From sialoliths (in salivary duct path, Wharton's/Stensen's duct), lymph node calcifications, and calcified lymph nodes.

---

Q18. Oral Manifestations of Stevens-Johnson Syndrome

DEFINITION:

CAUSES:

• Drugs (most common): Sulfonamides (cotrimoxazole), anticonvulsants (carbamazepine, phenytoin, lamotrigine), NSAIDs (oxicam type), allopurinol, antibiotics (ampicillin, quinolones)
• Infections: Mycoplasma pneumoniae (most common infectious cause in children), HSV
• Idiopathic

ORAL MANIFESTATIONS:

1. Painful, extensive oral ulceration - covering large areas of the oral mucosa
2. Hemorrhagic crusting of the lips (pathognomonic) - bloody, thick, dark brown/black crusts on the vermilion border of lips; the lips are matted together with hemorrhagic crusts
3. Blisters and erosions on buccal mucosa, tongue, floor of mouth, palate
4. Desquamation of the oral epithelium - large areas of necrotic epithelium slough off
5. Profuse salivation (hypersalivation) due to pain
6. Difficulty eating, drinking, and swallowing (odynophagia) - patients may be unable to take oral nutrition
7. Fetor oris (bad oral odor) from necrotic tissue
8. Mucosal bleeding
9. Secondary infection by Candida or bacteria
10. Scarring if severe - can lead to restricted mouth opening, adhesions

SYSTEMIC FEATURES (for context):

• Fever, malaise (prodrome)
• Skin: target lesions, bullae, widespread epidermal necrosis, Nikolsky's sign
• Eye: conjunctivitis, corneal ulcers → possible blindness
• Genital: ulcers, urethritis
• Respiratory: bronchial epithelial sloughing → respiratory failure (TEN)

MANAGEMENT:

• Stop the causative drug immediately (single most important step)
• Hospitalization - burns unit/ICU for severe cases
• Supportive: IV fluids, nutrition (nasogastric tube if oral intake impossible), wound care
• Oral: chlorhexidine rinses, viscous lidocaine for pain, topical corticosteroids for oral ulcers, antifungals for candidiasis
• Systemic: Cyclosporine (evidence in SJS/TEN), IVIG, systemic corticosteroids (controversial)
• Ophthalmology consult (eye involvement can lead to blindness)

---

Q19. Examination of TMJ

STEPS:

• Facial symmetry (deviation, swelling, muscle hypertrophy)
• Observe the mandibular opening path (straight, deviation, deflection)
• Note any facial asymmetry suggesting condylar hyperplasia/aplasia

• Maximum mouth opening (interincisal distance): Normal = 40-50 mm
  • <35 mm = restricted opening (trismus)
• Lateral excursions: Normal = 8-12 mm each side
• Protrusion: Normal = 6-12 mm
• Note whether movement is smooth or jerky

• Place fingertips over the preauricular region (directly over the condylar head)
• Palpate bilaterally during opening, closing, and lateral movements
• Note: tenderness, clicking, crepitus (grating sound), condylar movement
• Clicking: A distinct sound - may be opening click (disc displacement with reduction), closing click, or reciprocal click
• Crepitus: Grating sensation = articular surface irregularity (osteoarthritis, perforation of disc)
• Can also palpate via the external acoustic meatus (dorsal surface of condyle)

• Stethoscope placed over the TMJ
• Listen for clicks, crepitus, and their timing (opening/closing)

• Masseter: Bimanually palpated (fingers inside mouth on inner surface, thumb outside); assess tender points
• Temporalis: Palpated at temporal fossa, anterior and posterior fibers
• Medial pterygoid: Intraoral palpation on medial surface of ramus/posterior of mouth floor
• Lateral pterygoid: Cannot be palpated directly; provocation test - ask patient to resist jaw protrusion (pain = lateral pterygoid involvement)
• Sternocleidomastoid, trapezius: For referred pain in TMD

• Load test: Press up under chin while patient opens against resistance (tests joint loading)
• Distinguish arthralgia (joint pain) from myalgia (muscle pain)

• Occlusion: Assess for crossbite, deep bite, tooth wear (bruxism/attrition), missing teeth
• Midline discrepancy
• Fremitus (tooth mobility on occlusion)

• Cranial nerves V, VII, IX

• OPG (panoramic): gross condylar morphology, asymmetry
• TMJ tomography (transpharyngeal, transcranial views)
• CT scan: bony changes in detail
• MRI: soft tissue disc position and morphology (gold standard for disc displacement)

---

Q20. Duplicating X-ray Films

DEFINITION:

WHY DUPLICATE?

• To send a copy to a specialist, insurance company, referring dentist, or court while retaining the original
• To produce multiple copies for teaching, second opinions, or legal purposes
• To archive records while sending the original

DUPLICATING FILM:

• A special single-emulsion film coated on only one side (unlike regular dental film which is double-emulsion)
• Orthochromatic - sensitive to green light
• Reversal film / direct duplicating film - It is a solarization film with a characteristic reversed response:
  • Exposed to more light → becomes lighter (less dense) (opposite of normal film)
  • Exposed to less light → becomes darker
  • This reversal is essential: when placed against the original (which has dark and light areas), the duplicate accurately reproduces the same densities

EQUIPMENT NEEDED:

1. Duplicator unit (light box with ultraviolet/fluorescent light source and timer)
2. Duplicating film
3. Darkroom with appropriate safelight

PROCEDURE:

1. Go to darkroom; under safelight conditions, remove duplicating film from packet
2. Place the original radiograph on the duplicating unit's glass surface (image side up)
3. Place the emulsion side of the duplicating film (dull side) face down against the original
4. Close the lid tightly to ensure contact
5. Expose to the ultraviolet/fluorescent light for the recommended time (usually 2-10 seconds, determined by test exposures)
6. Process the duplicating film through normal developer and fixer (in standard darkroom processing)
7. The resulting duplicate is a copy with the same density and contrast as the original

KEY POINTS:

• Longer exposure time → lighter duplicate (due to solarization/reversal effect)
• Shorter exposure time → darker duplicate
• No radiation used - uses visible/UV light from the duplicator unit
• Contact is critical - any gap causes blurring of the duplicate
• Emulsion-to-emulsion contact between original film and duplicating film is essential

---

---

PERIODONTITIS

A Comprehensive Overview

---

1. DEFINITION

• Peri = around
• Odont = tooth
• Itis = inflammation

It is distinct from gingivitis, where inflammation is confined to the gingival soft tissues only, with no bone loss. Gingivitis is reversible; periodontitis is not fully reversible as lost bone and attachment do not spontaneously regenerate.

---

2. CLASSIFICATION (2017 AAP/EFP World Workshop - Current Classification)

• "Chronic periodontitis" and "Aggressive periodontitis" were merged under the single umbrella term "Periodontitis."
• A multidimensional Staging and Grading system (modelled on oncology) was introduced.

2A. TYPES OF PERIODONTAL DISEASE

• Necrotizing Ulcerative Gingivitis (NUG)
• Necrotizing Ulcerative Periodontitis (NUP)
• Necrotizing Stomatitis

• Diseases influencing the periodontal tissues (e.g., hematologic disorders, genetic disorders)

---

2B. STAGING OF PERIODONTITIS (Severity and Complexity)

---

2C. GRADING OF PERIODONTITIS (Rate of Progression and Risk)

---

3. EPIDEMIOLOGY

• Periodontitis is the most common chronic inflammatory disease in adults worldwide.
• Severe periodontitis (Stage III/IV) affects approximately 11% of the global population (~800 million people), making it the 6th most prevalent disease globally.
• It is the leading cause of tooth loss in individuals over 35-40 years.
• Prevalence increases with age.
• More common in males, smokers, and individuals with uncontrolled diabetes.
• Bidirectional relationship with systemic diseases (especially diabetes mellitus).

---

4. ETIOLOGY

Primary Etiologic Factor: Dental Plaque Biofilm

• Aggregatibacter (Actinobacillus) actinomycetemcomitans (Aa) - produces leukotoxin; important in aggressive/juvenile periodontitis
• Prevotella intermedia - elevated in NUG/NUP and pregnancy gingivitis
• Fusobacterium nucleatum - bridging organism in biofilm architecture

Virulence Factors of Periodontal Pathogens:

• Lipopolysaccharide (LPS) - triggers TLR-mediated immune activation
• Proteases (gingipains) of Pg - destroy collagen, immunoglobulins, complement components
• Leukotoxin of Aa - destroys neutrophils and macrophages
• Spirochete invasion (T. denticola) - direct tissue invasion
• Cross-feeding/synergism between Pg, Td and other plaque members promotes disease progression

---

5. PREDISPOSING (RISK) FACTORS

• Poor oral hygiene (primary driver)
• Calculus (supra- and sub-gingival)
• Malocclusion, crowding (reduces self-cleansing)
• Mouth breathing (gingival drying)
• Defective restorations (open margins, overhangs)
• Partial dentures (plaque retention)

• Diabetes mellitus (most important systemic risk factor; bidirectional - DM worsens periodontitis, periodontitis worsens glycemic control)
• Smoking (reduces tissue vascularity, impairs neutrophil function, masks bleeding on probing, single most important modifiable risk factor in HIV-negative patients)
• HIV infection/immunosuppression
• Medications: Calcium channel blockers, cyclosporine, phenytoin (drug-induced gingival overgrowth → more plaque retention)
• Hormonal changes: Pregnancy, puberty, oral contraceptives (increase vascular permeability and gingival response to plaque)
• Nutritional deficiencies: Vitamin C deficiency (scurvy) → severe gingival and periodontal breakdown
• Stress: Associated with NUP and worsening of chronic periodontitis
• Genetic susceptibility (IL-1 gene polymorphisms linked to increased susceptibility)

---

6. PATHOGENESIS

Stage 1 - Initial Lesion (0-4 days of plaque accumulation):

• Acute vascular response
• Increased gingival crevicular fluid flow
• Predominantly PMN (neutrophil) infiltration
• No clinical signs except slight erythema

Stage 2 - Early Lesion (4-7 days):

• More vascularity, capillary proliferation
• Lymphocytic infiltrate predominates
• Collagen destruction begins
• Early gingivitis clinically apparent (redness, bleeding on probing)

Stage 3 - Established Lesion (weeks-months):

• Dense plasma cell and lymphocyte infiltrate
• Significant collagen loss
• Pocket epithelium proliferates downward
• Clinical gingivitis - but reversible at this stage

Stage 4 - Advanced Lesion (months-years) = PERIODONTITIS:

• Plasma cells dominate
• Alveolar bone resorption begins (osteoclastic activity driven by cytokine cascade)
• Key cytokines driving bone loss: IL-1β, TNF-α, PGE₂, RANKL
• Junctional epithelium migrates apically → true periodontal pocket formation
• Loss of clinical attachment (CAL)
• Progressive destruction if untreated → tooth mobility → tooth loss

Mechanisms of Bone Destruction:

• Bacterial LPS activates macrophages → release of IL-1β, TNF-α → stimulate fibroblasts and osteoblasts to release RANKL
• RANKL (Receptor Activator of NF-κB Ligand) activates osteoclasts → bone resorption
• This is the same pathway exploited by the drug denosumab (anti-RANKL) in osteoporosis

---

7. CLINICAL FEATURES

Signs and Symptoms:

• Redness and color change (from coral pink to red/purplish-red)
• Swelling and loss of normal knife-edge gingival contour
• Bleeding on probing (BOP) - cardinal sign; indicates active inflammation
• Spontaneous bleeding in severe cases
• Gingival recession (in some patients, gingiva recedes rather than pocketing)
• Pus discharge from pockets (suppuration)
• Bad breath (halitosis) - due to volatile sulfur compounds from anaerobic bacteria

• True periodontal pocket: apical migration of junctional epithelium with bone loss
• Probing depth > 3 mm = abnormal
• Pocket measured by WHO probe or UNC-15 probe

• Horizontal bone loss (most common type - uniform crestal bone loss)
• Vertical/angular bone loss (creates infrabony pockets - indicates more aggressive disease)
• Furcation involvement in multi-rooted teeth

• Tooth mobility (grades I, II, III)
• Pathological migration/drifting of teeth
• Spacing between teeth (diastemata) due to bone loss and tongue pressure
• Sensitivity to hot/cold due to root exposure
• Food impaction in interdental areas

• Bleeding gums (often first symptom patient notices)
• Pain unusual unless acute exacerbation or abscess
• Loose teeth
• Bad taste in mouth

---

8. TYPES IN DETAIL

8A. Chronic Periodontitis (now just "Periodontitis" in 2017 classification)

• Most prevalent form
• Affects adults >35 years
• Slow to moderate progression
• Amount of destruction consistent with local factors
• Associated with subgingival calculus

8B. Necrotizing Ulcerative Periodontitis (NUP)

• Distinct clinicopathological entity
• Acute onset, extremely painful - unlike ordinary periodontitis
• Punched-out, crater-like destruction of interdental papillae with overlying grey necrotic pseudomembrane
• Characteristic fetid odor (halitosis)
• Systemic features: fever, malaise, regional lymphadenopathy
• Rapid destruction of interdental bone creating "reverse architecture"
• Etiology: Fusospirochetal infection (Fusobacterium, spirochetes, Prevotella intermedia)
• Risk factors: HIV/AIDS, severe immunocompromise, malnutrition, stress, poor oral hygiene, smoking
• In HIV patients: can progress to severe NUP with exposure of alveolar bone and sequestration
• Treatment: Debridement + metronidazole 250 mg TID for 7 days + chlorhexidine rinses + pain control

8C. Localized Aggressive Periodontitis (now Stage III/IV, Grade C - Molar-Incisor pattern)

• Previously "Localized Juvenile Periodontitis"
• Affects adolescents and young adults
• Classic pattern: First molars and central incisors (6s and 1s)
• Rapid bone loss ("arc-shaped" bone loss on radiograph around first molars)
• Amount of destruction disproportionate to plaque levels (little plaque, severe bone loss)
• Associated with A. actinomycetemcomitans (leukotoxin impairs neutrophil response)
• Family history positive (autosomal dominant with incomplete penetrance)

8D. Generalized Aggressive Periodontitis (now Stage III/IV, Grade C - Generalized)

• Generalized interproximal attachment loss involving ≥3 teeth other than first molars and incisors
• Affects young adults (<30 years typically)
• Rapid progression
• Episodic bursts of disease activity

---

9. PERIODONTAL EXAMINATION

• Color, contour, consistency, texture
• Presence of bleeding on probing (BOP score - %)
• Presence of suppuration

• 6-point probing per tooth (DB, B, MB, DL, L, ML)
• Probing depth (PD): Gingival margin to base of pocket
• Clinical Attachment Level (CAL): CEJ to base of pocket = PD ± recession
• Normal probing depth: 1-3 mm

• Periapical radiographs (gold standard for individual tooth assessment)
• Bitewing radiographs (for posterior interproximal bone levels)
• OPG (panoramic view) - screening, full arch overview
• CBCT - for advanced cases, implant planning, bone defect morphology

• Loss of alveolar crest height (normal: within 1-2 mm of CEJ)
• Widening of periodontal ligament space
• Loss of lamina dura
• Horizontal and vertical bone loss patterns
• Furcation involvement (triangular radiolucency at furcation area)

• Class I: Barely perceptible movement (<0.2 mm horizontal)
• Class II: Perceptible movement (0.2-1 mm horizontal)
• Class III: Movement >1 mm horizontal OR vertical (depressible)

• Class I: Probe enters <3 mm horizontally
• Class II: Probe enters ≥3 mm but does not pass through
• Class III: Probe passes through furcation (through-and-through)

---

10. SYSTEMIC ASSOCIATIONS

---

11. MANAGEMENT

STEP 1: Patient Education and Risk Factor Modification

• Oral hygiene instruction (OHI): Correct brushing technique (Modified Bass method), interdental cleaning (floss, interdental brushes)
• Smoking cessation counseling
• Diabetes management (coordinate with physician; target HbA1c <7%)
• Nutritional counseling

---

STEP 2: Cause-Related Therapy (Supragingival and Subgingival Debridement)

• Supragingival scaling: Removal of calculus and plaque above the gingival margin
• Subgingival scaling and root planing (deep scaling): Mechanical debridement of subgingival calculus, disruption of biofilm, and removal of toxin-impregnated cementum
• Performed with: Hand instruments (Gracey curettes, scalers) + Ultrasonic/sonic scalers
• Single visit full-mouth debridement (FMD) vs. quadrant-by-quadrant
• Re-evaluation at 4-8 weeks post SRP to assess treatment response

• Tetracycline fibers, chlorhexidine chips, minocycline microspheres, doxycycline gel - placed directly into periodontal pockets
• Used as adjuncts to SRP in localized deep pockets (≥5 mm) that do not respond to SRP alone

• Reserved for aggressive/refractory periodontitis, NUP, medically compromised patients

• Chlorhexidine gluconate (0.12-0.2%) mouth rinse - preferred antiseptic rinse; 2× daily; effective against plaque and gingivitis; not a long-term substitute for mechanical cleaning
• Povidone-iodine irrigation (subgingival)

---

STEP 3: Re-evaluation (4-8 Weeks Post-SRP)

• Assess response: BOP score, probing depths, CAL
• If pockets ≤4 mm → periodontal maintenance
• If pockets ≥5-6 mm persist → consider surgical intervention

---

STEP 4: Periodontal Surgery (For Non-Responding Cases)

• Gingivectomy - for fibrous suprabony pockets
• Flap surgery (Modified Widman Flap, apically repositioned flap) - to access deeper root surfaces

• Guided Tissue Regeneration (GTR) - membrane barriers to exclude epithelium, allow periodontal ligament and bone to regenerate
• Bone grafts: Autografts, allografts, xenografts, alloplasts
• Enamel Matrix Derivative (Emdogain® - amelogenin proteins) - promotes PDL and bone regeneration
• Growth factors (PDGF, FGF)

• Free gingival graft, connective tissue graft - for root coverage in recession defects

---

STEP 5: Maintenance (Supportive Periodontal Therapy - SPT)

• Every 3 months for active periodontitis; 6 months for stable cases
• Professional scaling, review OHI, reassess probing depths
• Life-long commitment required as periodontitis cannot be "cured," only controlled

---

12. PERIODONTAL ABSCESS

• Gingival abscess (within gingival tissues only)
• Periodontal abscess (in the periodontal pocket wall)
• Pericoronal abscess (around a partially erupted tooth)

• Acute onset swelling, throbbing pain, tenderness on percussion
• Suppuration/pus discharge from pocket
• Tooth mobile and tender
• Regional lymphadenopathy, fever in severe cases

• Drainage (through the pocket or incision and drainage if fluctuant)
• Scaling/debridement once acute phase resolves
• Antibiotics if systemic involvement: Amoxicillin 500 mg TID or Metronidazole 400 mg TID × 5-7 days
• Analgesics: Ibuprofen 400-600 mg QID

---

13. RADIOGRAPHIC FEATURES OF PERIODONTITIS

---

14. SUMMARY TABLE

---

ATHEROSCLEROSIS

A Comprehensive Review

---

1. DEFINITION

• Athero (Greek: gruel/porridge) - refers to the soft lipid core
• Sclerosis (Greek: hardening) - refers to the fibrous component

It is the single most important disease in the Western world, responsible for roughly half of all deaths and the underlying cause of coronary artery disease, stroke, and peripheral vascular disease.

• Robbins & Cotran Pathologic Basis of Disease

---

2. ARTERIOSCLEROSIS vs ATHEROSCLEROSIS

---

3. EPIDEMIOLOGY

• Most common cause of morbidity and mortality in Western nations
• Myocardial infarction alone accounts for ~25% of all deaths in the USA
• Death rates from coronary artery disease in Eastern Europe are 3-5× higher than the USA, and 7-12× higher than Japan
• Africa, India, and Southeast Asia now have death rates from coronary artery disease exceeding that of the USA, driven by urbanization and Western diet adoption
• Risk identified through landmark Framingham Heart Study (prospective cohort study)

---

4. RISK FACTORS

4A. NON-MODIFIABLE (Constitutional) Risk Factors

4B. MODIFIABLE Risk Factors

4C. Additional / "Novel" Risk Factors

• Obesity (especially abdominal/visceral adiposity)
• Physical inactivity
• Metabolic syndrome (insulin resistance, central obesity, dyslipidemia, hypertension)
• Lipoprotein(a) - elevated levels are an independent risk factor
• Homocysteinemia - damages endothelium; thrombogenic
• Chlamydia pneumoniae infection (controversial)
• Chronic kidney disease
• Sleep apnea
• Stress / Type A personality

---

5. PATHOGENESIS - "Response to Endothelial Injury" Hypothesis

STEP-BY-STEP SEQUENCE:

Step 1 - Endothelial Injury and Dysfunction

• The initiating event is injury to the vascular endothelium (EC)
• Causes of endothelial injury/dysfunction:
  • Hemodynamic disturbance (turbulent flow, especially at branch points and curvatures)
  • Oxidized LDL lipoproteins
  • Cigarette smoke toxins
  • Hypertension (mechanical shear stress)
  • Elevated homocysteine
  • Infectious agents (CMV, Chlamydia)
  • Inflammatory cytokines
• Injured ECs: reduce nitric oxide (NO) production (loss of vasodilator and anti-adhesion function); increase expression of adhesion molecules (VCAM-1, ICAM-1, E-selectin)

Step 2 - Monocyte Adhesion and Migration (Formation of Fatty Streak)

• Circulating monocytes and LDL accumulate at the site of endothelial injury
• Monocytes adhere to the activated endothelium via VCAM-1 and other adhesion molecules
• Monocytes cross the endothelium and enter the intima
• In the intima, monocytes differentiate into macrophages
• Macrophages ingest and oxidize accumulated LDL via scavenger receptors → become foam cells (lipid-laden macrophages with foamy appearance due to lipid droplets)
• Accumulation of foam cells produces the first visible lesion: the fatty streak

Step 3 - Inflammation and Cytokine Release

• Foam cells and activated ECs release:
  • IL-1β, TNF-α → recruit more monocytes/macrophages, T lymphocytes
  • Chemokines (MCP-1) → attract more monocytes
  • Growth factors (PDGF, FGF) → stimulate smooth muscle cell (SMC) migration and proliferation
• T lymphocytes are also recruited → release IFN-γ → activates macrophages and ECs further
• Cholesterol crystals activate the NLRP3 inflammasome → IL-1β production (major atherogenic cytokine)
• Oxidized LDL is also directly cytotoxic to ECs and SMCs
• This self-amplifying inflammatory cycle drives progressive lesion formation

Step 4 - Smooth Muscle Cell (SMC) Migration and Proliferation

• Growth factors (PDGF from platelets and macrophages, FGF, TGF-β) stimulate SMC migration from the media to the intima
• SMCs undergo a phenotypic change: from contractile (normal medial SMC) to synthetic (proliferative) phenotype
• Intimal SMCs proliferate and synthesize ECM (collagen, proteoglycans, elastin) in a process analogous to wound healing
• This converts the early fatty streak into a more organized fibrous lesion - the atherosclerotic plaque

Step 5 - Plaque Formation and Growth

• The mature atherosclerotic plaque (atheroma) consists of:
  • Fibrous cap (surface layer of SMCs, dense collagen, proteoglycans)
  • Atheromatous core (necrotic center with lipid debris, cholesterol crystals, dead foam cells, calcifications)
  • Shoulder regions - more cellular, with SMCs, macrophages, T lymphocytes
• The plaque grows eccentrically into the lumen
• Initially, outward (positive) remodeling compensates (Glagov phenomenon) - lumen is preserved until ~40% of vessel wall is involved
• Eventually, the plaque encroaches on the lumen, reducing blood flow

---

6. MORPHOLOGY OF LESIONS (Stages)

Stage 1 - Fatty Streak

• Earliest lesion - can begin in aortas of infants and virtually all adolescents
• Gross: Small, flat, yellow macules that coalesce into streaks 1 cm or longer
• Slightly raised; do NOT obstruct blood flow
• Microscopy: Lipid-filled foam cells (macrophages + some SMCs) in the intima
• Potentially reversible with risk factor modification
• Not all fatty streaks progress to plaques

Stage 2 - Gelatinous Lesion / Pre-atheroma

• Focal increase in smooth muscle cells and matrix in intima
• Bridge between fatty streak and fibrous plaque

Stage 3 - Fibrous (Atherosclerotic) Plaque - Established Atheroma

• Yellow-tan raised lesions on the luminal surface of arteries
• Vary in size; may coalesce into large masses
• Eccentric lesions (occupy only a portion of vessel wall circumference)
• Superimposed thrombus appears red-brown

1. Lower abdominal aorta and iliac arteries (most severely involved)
2. Coronary arteries
3. Popliteal arteries
4. Internal carotid arteries
5. Vessels of the circle of Willis

• Upper extremity vessels, mesenteric, and renal arteries (except ostia) relatively spared

1. Cells: SMCs, macrophages (foam cells), T lymphocytes
2. Extracellular matrix: Collagen, elastic fibers, proteoglycans
3. Intracellular and extracellular lipids: Cholesterol crystals, cholesterol esters
4. Calcifications: In advanced/late-stage plaques

• Fibrous cap (superficial): Dense collagen synthesized by SMCs; provides structural integrity
• Atheromatous/necrotic core (deep): Soft, grumous lipid material, cholesterol crystals, necrotic debris, dead foam cells
• Shoulder regions (lateral to cap): More cellular; more vulnerable to rupture

Stage 4 - Complicated Plaque

1. Calcification - dystrophic calcification of dead cells and lipids → hardening of arteries
2. Ulceration/Erosion - loss of fibrous cap surface
3. Thrombosis - superimposed thrombus on ulcerated/eroded plaque → acute occlusion
4. Hemorrhage into plaque - rupture of intraplaque neovessels (vasa vasorum) → sudden plaque expansion
5. Aneurysm formation - plaque thickening impedes oxygen diffusion to media → medial ischemia and weakening

---

7. STABLE vs. VULNERABLE (UNSTABLE) PLAQUES

Mechanisms of Plaque Rupture:

• Activated macrophages in the vulnerable plaque produce metalloproteinases (MMPs) → degrade collagen in the fibrous cap → thin, weaken the cap
• Reduced collagen synthesis by dying SMCs further weakens the cap
• IFN-γ from T cells inhibits SMC collagen synthesis
• Physical stresses: blood pressure spikes, adrenergic surges (circadian peak: 6 AM-12 noon - explains morning peak of MI)

---

8. CONSEQUENCES / COMPLICATIONS

8A. Coronary Artery Disease (IHD)

• Stable angina pectoris: Gradual luminal narrowing (>70%) → effort-induced ischemia (fixed obstruction)
• Unstable angina: Plaque rupture with non-occlusive thrombus → rest pain
• Myocardial infarction: Plaque rupture + complete occlusive thrombus → transmural infarction (STEMI) or subendocardial infarction (NSTEMI)
• Sudden cardiac death: Plaque rupture + ventricular arrhythmia

8B. Cerebrovascular Disease

• Ischemic stroke / TIA: Carotid artery plaque → embolization → cerebral infarction
• Multi-infarct dementia: Repeated small emboli

8C. Peripheral Vascular Disease

• Lower extremity arterial disease → claudication, rest pain, ischemic ulcers, gangrene
• Renovascular disease → renal artery stenosis → secondary hypertension

8D. Aortic Aneurysm

• Atherosclerosis of aorta → medial ischemia and weakening → aneurysm (especially abdominal aortic aneurysm, below the renal arteries)
• Risk of rupture → catastrophic hemorrhage
• Aneurysm types:
  • Saccular: Discrete spherical outpouching
  • Fusiform: Circumferential dilation

8E. Mesenteric Ischemia

• Celiac/SMA/IMA involvement → bowel ischemia

---

9. BIOCHEMICAL MECHANISMS IN DETAIL

Role of LDL and Oxidized LDL:

• Native LDL enters the subendothelial space → becomes oxidized LDL (oxLDL) by ROS from macrophages/ECs
• OxLDL is taken up by macrophage scavenger receptors (SR-A, CD36) (unlike normal LDL receptor, scavenger receptors are NOT down-regulated by intracellular cholesterol accumulation → unlimited uptake → foam cell formation)
• OxLDL effects:
  • Cytotoxic to ECs and SMCs
  • Promotes monocyte recruitment (upregulates MCP-1)
  • Stimulates growth factor and cytokine release
  • Pro-thrombotic (reduces thrombomodulin)

Role of HDL (Protective):

• HDL mediates reverse cholesterol transport - removes cholesterol from foam cells/peripheral tissues → liver for catabolism
• HDL also has anti-oxidant and anti-inflammatory properties

Cholesterol Crystals and Inflammasome:

• Cholesterol crystals accumulate in macrophage lysosomes → lysosomal damage → activates NLRP3 inflammasome → caspase-1 activation → IL-1β and IL-18 secretion → amplified inflammation

---

10. HISTOPATHOLOGY SUMMARY

---

11. PREVENTION AND TREATMENT

Primary Prevention (Risk Factor Modification):

• Lipid lowering: Statins (HMG-CoA reductase inhibitors) - first line; reduce LDL, stabilize plaques (anti-inflammatory, reduce plaque macrophage content), prevent cardiovascular events
• Blood pressure control: Target <130/80 mmHg; ACE inhibitors, ARBs, CCBs
• Smoking cessation
• Glycemic control in diabetes: Target HbA1c <7%
• Exercise: 150 min/week moderate aerobic activity
• Diet: Mediterranean diet; reduce saturated fats, trans fats; increase soluble fiber, omega-3 fatty acids
• Aspirin (low-dose 75-100 mg): Anti-platelet for secondary prevention (not recommended for primary prevention routinely due to bleeding risk)

Pharmacotherapy:

Interventional / Surgical:

• Percutaneous Coronary Intervention (PCI): Balloon angioplasty + drug-eluting stent placement
• Coronary Artery Bypass Grafting (CABG): For multi-vessel or left main disease
• Carotid endarterectomy: For symptomatic high-grade carotid stenosis
• Peripheral vascular interventions: Angioplasty, bypass grafts for limb ischemia

---

12. KEY MOLECULAR MEDIATORS SUMMARY

---

13. SUMMARY TABLE

1. Vesiculobullous & ulcerative lesions - Pemphigus vulgaris, Pemphigoid, Erythema multiforme, Aphthous ulcers, Herpes simplex/zoster, Stevens-Johnson syndrome, ANUG
2. White/red lesions & potentially malignant disorders - Lichen planus, Leukoplakia, OSMF, Candidiasis, Erythroplakia
3. Orofacial pain - Trigeminal neuralgia, MPDS/TMD, Atypical facial pain, Trismus, Eagle's syndrome
4. Salivary gland disorders - Sjogren's syndrome, Sialadenitis, Sialolithiasis, Mucocele, Pleomorphic adenoma, Xerostomia
5. Oral manifestations of systemic disease - Anemia, Hemophilia/bleeding disorders, Leukemia, Diabetes, HIV/AIDS, Renal failure, Cardiac patient dental management, Hyperparathyroidism, Syphilis
6. Cysts, tumors & bone lesions - Dentigerous cyst, OKC, Ameloblastoma, Periapical cyst/granuloma, Paget's disease, Fibrous dysplasia, Cherubism, Osteosarcoma, Osteomyelitis
7. Pigmentation & genetic/developmental conditions - Café-au-lait spots, Peutz-Jeghers, Albright's syndrome, Gardner's syndrome, Ectodermal dysplasia, Gorlin-Goltz, Cleidocranial dysostosis

---

Trigeminal Neuralgia

Note: The textbook library does not contain a "Piyush" oral medicine textbook (no such title is indexed). The content below is drawn from Bradley and Daroff's Neurology in Clinical Practice and Goldman-Cecil Medicine - both authoritative sources that cover trigeminal neuralgia in detail consistent with what oral medicine textbooks typically present.

---

Definition

• Goldman-Cecil Medicine, p. 1072

---

Epidemiology

• Incidence: ~4 per 100,000 individuals
• Most common between 50-70 years of age
• Slightly more common in women (1.5:1 female-to-male ratio)
• Begins after age 40 in 90% of patients
• Incidence progressively increases with age
• Rare familial cases have been described
• Bradley and Daroff's Neurology, p. 2497-2498

---

Classification (ICHD-3)

• Bradley and Daroff's Neurology, p. 2498

---

Pathogenesis & Etiology

• Classical TN is related to neurovascular compression of the trigeminal nerve by neighboring vessels:
  • Superior cerebellar artery (most common)
  • Anterior and posterior inferior cerebellar arteries
  • Superior petrosal vein
• Vascular compression increases with age and leads to focal demyelination of primary trigeminal afferents near the nerve root entry zone (at the pons)
• Demyelination leads to focal hyperexcitability and ectopic/repetitive neuronal discharges
• In younger patients: Multiple sclerosis is an important cause
• In older patients: Ectatic vertebrobasilar artery compression
• Bradley and Daroff's Neurology, p. 2498

---

Clinical Features

• Paroxysmal, electric shock-like, shooting, lancinating pain
• Lasts only seconds (up to 2 minutes per attack)
• May repeat at short intervals so attacks blur together
• After many attacks, a residual lingering facial pain may persist
• Usually unilateral

• V2 + V3 combination is the most common
• V2 (cheek/upper teeth) alone or V3 (chin/lower teeth) alone also common
• V1 (ophthalmic division) - extremely rare to be involved alone
• Pain during sleep is uncommon but can occur

• Most commonly near the nasolabial fold
• Trigger zone may be remote from the site of pain
• Common triggers: touching the face, chewing, teeth brushing, talking, swallowing, cool breeze striking the face

• Frequent attacks may cause weight loss, dehydration, or depression
• Goldman-Cecil Medicine, p. 1081; Bradley and Daroff's Neurology, p. 2497-2498

---

Physical Findings

• Classical TN: No sensory impairment; motor division of the nerve is intact
• Presence of sensory loss or masticatory muscle weakness suggests a secondary cause (more accurately called trigeminal neuropathy)
• Secondary causes to think about: lesion/mass affecting the gasserian ganglion, main sensory root, or root entry zone in the pons
• Bradley and Daroff's Neurology, p. 2498

---

Diagnosis

• Paroxysmal attacks of pain lasting seconds to 2 minutes
• Affects one or more divisions of the trigeminal nerve
• Pain is intensely sharp, stabbing, or precipitated by a trigger
• Each attack is stereotypical
• No other neurological deficits (in classical/idiopathic TN)

• MRI: Primary investigation - to look for structural lesions (pontine lacunar infarct, demyelinating plaque, meningioma, schwannoma, skull base malignancy)
• High-resolution MRI/MRA: May identify vascular compression
• EMG and blink reflex studies: Normal in idiopathic TN
• No accompanying laboratory or radiographic abnormalities in idiopathic TN

• Trigeminal autonomic cephalgia (has autonomic accompaniments)
• Atypical facial pain
• Idiopathic stabbing headache
• Tolosa-Hunt syndrome (inflammatory, anterior cavernous sinus)
• Glossopharyngeal neuralgia
• Goldman-Cecil Medicine, p. 1086; Bradley and Daroff's Neurology, p. 2498

---

Course & Prognosis

• Frequently exacerbating and remitting course over many years
• Spontaneous or medication-induced remissions are possible
• Microvascular decompression (MVD) can provide long-term relief

---

Treatment

Medical Management

• Carbamazepine side effects: vertigo, drowsiness, ataxia (especially if introduced quickly in elderly); agranulocytosis risk
• Monitoring: CBC, LFTs, serum sodium for first few months, then annually

Acute/Emergency Treatment

• IV fosphenytoin at 15-20 mg PE/kg for a patient in the midst of a severe attack
• Anesthetizing the ipsilateral conjunctival sac with proparacaine (topical ophthalmic anesthetic) - provides relief for several hours to days

Surgical Management

• Young, healthy patient refractory to medications: Posterior fossa MVD is the procedure of choice - longest pain relief, preserves sensation
• Elderly or medically compromised patient: Percutaneous procedures (radiofrequency thermocoagulation or balloon compression) are preferred
• Treatment must be individualized
• Bradley and Daroff's Neurology, p. 2498-2499; Goldman-Cecil Medicine, p. 1091

---

Summary Table

---

Regarding the "Piyush" textbook specifically: The medical library database does not contain any textbook by an author named "Piyush" or a standalone oral medicine title under that name. If you have a specific edition (e.g., "Textbook of Oral Medicine by Anil Govindrao Ghom" or similar), please let me know and I can refine the search. The content above covers trigeminal neuralgia comprehensively as it is presented in standard clinical textbooks.A BDS + MBA (from an IIM) is a powerful combination that opens doors well beyond clinical dentistry — healthcare management, consulting, pharma, and medical devices typically pay ₹15–30 LPA at entry level, with senior roles going much higher. Let me get you current, specific data.

---

BDS + MBA (IIM) - Salary & Career Options

---

Which IIMs Offer Relevant Programs?

For the flagship PGP (general MBA) at IIM-A/B/C/L, BDS holders are eligible via CAT and are evaluated like any other candidate. A BDS background is actually a differentiator in interviews for healthcare-related roles.

---

Salary Data from Official IIM Placement Reports (2024-2025)

IIM Jammu - MBA HA&HM (2024 Placement Report)

---

IIM Bodh Gaya - MBA-HHM (2025)

• 61 students placed out of 68 eligible
• Average CTC across all programs (including MBA): ₹14.96 LPA
• Highest: ₹48.58 LPA

---

IIM General PGP (if you get into IIMA/B/C via CAT)

---

Career Roles & Salaries for BDS + MBA

---

Key Sectors That Actively Hire BDS + MBA Graduates

1. Pharmaceuticals - Largest recruiter (31.8% of IIM HA&HM offers). Your clinical knowledge helps in medical affairs, regulatory, and field medical roles.
2. IT & Consulting - Healthcare digital transformation is booming. Companies like Cognizant, Carelon, Infosys Health hire heavily.
3. Medical Devices - Companies like Meril, J&J, Medtronic value clinical background for product and sales roles.
4. Hospital Chains - Apollo, Narayana, Fortis, Shalby for strategic/operations roles.
5. Health Insurance - Star Health, HDFC Life, Digit for product and claims roles.
6. Health-Tech Startups - Highest growth potential; equity + salary.

---

Realistic Salary Trajectory (BDS + IIM MBA)

---

Important Note on IIM Selection

• Specialist healthcare MBA (IIM Jammu HA&HM, IIM Bodh Gaya HHM): Easier admission, guaranteed healthcare placement network, avg ₹13-14 LPA.
• General IIM PGP (IIM-A/B/C via CAT): Very competitive, but opens doors to consulting, FMCG, tech - avg ₹30-35 LPA. Your BDS background becomes your interview differentiator for healthcare consulting roles at McKinsey, BCG, or Deloitte.

ST. JOSEPH DENTAL COLLEGE, ELURU

Oral Medicine and Radiology - II Internal Exam, IV BDS

Complete Answers to All 20 Questions

---

SECTION I: ESSAY QUESTIONS (2 × 9 = 18 marks)

---

Q1. Classify ulcerative and vesiculobullous lesions. Write in detail about history, clinical and oral manifestations, investigations, and management of Pemphigus Vulgaris.

---

A. CLASSIFICATION OF ULCERATIVE AND VESICULOBULLOUS LESIONS

ULCERATIVE LESIONS

• Mechanical (denture trauma, cheek bite)
• Chemical burns (aspirin burns, acid burns)
• Thermal burns

• Viral: Herpes simplex, Herpes zoster, Hand-foot-mouth disease
• Bacterial: Primary syphilis (chancre), Tuberculosis, Noma (cancrum oris)
• Fungal: Histoplasmosis, Mucormycosis

• Recurrent Aphthous Stomatitis (minor, major/Sutton's disease, herpetiform)
• Behcet's syndrome
• Reiter's syndrome
• Erythema multiforme
• Lichen planus (erosive type)

• Squamous cell carcinoma
• Salivary gland malignancies

• Blood dyscrasias (leukemia, agranulocytosis)
• Dermatological diseases (Pemphigus, Pemphigoid)
• Nutritional deficiencies

---

VESICULOBULLOUS LESIONS

• Herpes simplex virus (HSV-1, 2)
• Varicella zoster
• Hand, foot, and mouth disease
• Erythema multiforme
• Angina bullosa haemorrhagica

---

B. PEMPHIGUS VULGARIS (PV)

DEFINITION

• First described autoantibodies identified in 1964 by Beutner and Jordon.

---

HISTORY / EPIDEMIOLOGY

• Age: Most commonly fifth to sixth decade (40-60 years); oral lesions may precede skin lesions.
• Sex: Roughly equal male-to-female ratio, slight female predilection in some studies.
• Race/Ethnicity: Higher prevalence in Ashkenazi Jews and people of Mediterranean or Middle Eastern descent.
• Course: Chronic, relapsing - remitting. Prior to corticosteroids, mortality was nearly 100%.
• Onset: Oral lesions are the presenting sign in ~60-70% of patients and may precede skin lesions by an average of 5 months (up to 5 years in some cases).

---

CLINICAL MANIFESTATIONS

• Painful, irregular erosions and ulcers of the oral mucosa - the most common presenting sign
• Blisters are rarely seen intact in the mouth because they rupture readily, leaving behind ragged, bleeding erosions with overhanging epithelium
• Most commonly involved sites: buccal mucosa, palate, gingiva, tongue, lower lip
• Lesions are extremely painful, interfering with eating and drinking
• Positive Nikolsky's sign in the oral cavity - lateral pressure on apparently normal mucosa causes new blister formation
• Early lesions may appear as areas of desquamative gingivitis
• Oropharyngeal involvement seen in 87% of PV patients; nasal mucosa (76%), pharynx (66%), larynx (55%) also commonly affected

• Flaccid blisters (easily ruptured) on normal-looking or erythematous skin
• Blisters rupture to leave large painful erosions
• Common sites: scalp, face, axillae, groin, trunk
• Nikolsky's sign positive on skin: rubbing normal-appearing skin causes blister formation
• Asboe-Hansen sign (Bulla spread sign): pressure on intact blister causes lateral spread
• Healing with hyperpigmentation but no scarring in typical PV
• Pemphigus vegetans variant: exuberant granulation tissue (vegetations) in intertriginous areas (groin, axilla)

---

PATHOGENESIS

• Autoantibodies: IgG antibodies against Desmoglein 3 (mucosal type - oral lesions dominant) and Desmoglein 1 (mucocutaneous type - skin lesions added)
• Desmogleins are transmembrane cadherins found in desmosomes that maintain keratinocyte-to-keratinocyte adhesion
• Antibody binding leads to acantholysis (loss of cell-cell adhesion) and blister formation
• Suprabasal split - basal cells remain attached to the basement membrane like a "row of tombstones"
• Desmoglein compensation theory: Explains tissue specificity - oral mucosa expresses predominantly Dsg3, so anti-Dsg3 alone causes oral disease; skin expresses both Dsg1 and Dsg3, so both antibodies needed for skin blisters

---

INVESTIGATIONS

• Punch biopsy from the edge of a fresh lesion (perilesional tissue best)
• Shows: suprabasal acantholysis - cleft just above the basal layer
• "Tombstone appearance" - single row of basal cells remaining attached to basement membrane
• Acantholytic cells (Tzanck cells) in the blister cavity - round cells with large nuclei and prominent nucleoli

• Perilesional biopsy (4-6 mm punch) sent in Michel's transport medium
• Shows: IgG and C3 deposition in a fishnet/lace-like pattern throughout the epidermis (intercellular)
• Sensitivity ~90%

• Patient serum applied to monkey esophagus or normal human skin substrate
• Detects circulating anti-cell surface antibodies
• Titer correlates with disease activity

• Detects and quantifies anti-Desmoglein 1 and anti-Desmoglein 3 antibodies specifically
• Levels correlate with disease activity and can guide treatment
• Highly specific and sensitive

• Smear from base of fresh blister
• Shows Tzanck cells (acantholytic cells) - round cells with large vesicular nucleus
• Rapid but not specific (also positive in herpes)

• CBC, blood glucose, serum electrolytes (baseline before steroids)
• Chest X-ray (to rule out infections before immunosuppression)
• Serum albumin (nutritional status)

---

MANAGEMENT

• Prednisolone: 1 mg/kg/day orally (60-100 mg/day)
• Dexamethasone cyclophosphamide pulse (DCP pulse): 100 mg dexamethasone IV over 3 days monthly + oral cyclophosphamide 50 mg/day

• Azathioprine (1.5-2.5 mg/kg/day) - most commonly used adjuvant
• Mycophenolate mofetil (2-3 g/day) - good alternative with less hepatotoxicity
• Cyclophosphamide - for refractory cases
• Methotrexate - for mild-moderate disease

• Targets CD20+ B lymphocytes (depletes autoreactive B cells)
• 375 mg/m² IV weekly × 4 doses (lymphoma protocol) OR
• 1000 mg IV × 2 doses (rheumatoid arthritis protocol, 2 weeks apart)
• Now considered first-line along with corticosteroids for moderate-to-severe disease
• High remission rates; may allow steroid tapering

• 2 g/kg per cycle over 3-5 days
• Rapidly reduces pathogenic antibody levels
• Used for severe, refractory, or flaring disease

• Removes circulating autoantibodies rapidly
• Used in acute severe disease

• Triamcinolone acetonide 0.1% in Orabase - for localized oral erosions
• Chlorhexidine mouth rinses (0.12-0.2%) - prevent secondary infection
• Viscous lidocaine for pain relief before meals
• Soft, non-irritating diet

• Anti-Dsg3/Dsg1 ELISA titers to monitor response
• Regular blood counts, liver and kidney function
• Bone density (long-term steroid use)
• Blood glucose monitoring

---

---

Q2. Write in detail about X-ray tube head with a neat labelled diagram. Write about production of X-rays.

---

X-RAY TUBE HEAD

---

COMPONENTS OF THE X-RAY TUBEHEAD

• Made of aluminium or steel
• Lead-lined to prevent radiation leakage
• Filled with insulating oil (transformer oil) for cooling and electrical insulation

• Contains the filament (made of tungsten wire, coiled)
• Filament is enclosed in a focusing cup (molybdenum)
• When current passes through the filament, it heats up and releases electrons by thermionic emission (Edison effect)
• The focusing cup directs the electron beam towards the anode
• Tube current (mA) controls the number of electrons (quantity of X-rays)

• Contains the target - a small tungsten block embedded in a copper stem
• Tungsten is used because: high atomic number (74), high melting point (3422°C), high density, good thermal conductivity
• Focal spot: Small area on the anode where electrons strike and X-rays are produced
• Target angle (anode angle): 6-20° - determines effective focal spot size
• Copper dissipates heat generated during X-ray production
• Stationary anode used in dental X-ray tubes (rotating anodes in medical CT)

• High vacuum maintained inside
• Allows electrons to travel without collision

• Placed in the path of the X-ray beam
• Function: Removes low-energy (soft, long wavelength) X-rays that would be absorbed by patient tissues without contributing to the image
• Thickness: 1.5 mm (for <70 kVp) or 2.5 mm (for ≥70 kVp) as per regulations
• Increases mean photon energy of the beam (beam hardening)

• A lead disc or plate with a central aperture
• Function: Restricts and shapes the X-ray beam to the required field size
• Reduces patient radiation dose by limiting the area irradiated
• Types: Circular, rectangular (rectangular collimation reduces dose significantly)

• Extends from the collimator to the patient's face
• Functions: Indicates where to position the X-ray beam; establishes source-to-skin distance; shapes the beam
• Types: Round/circular cone, Rectangular PID (RINN type)
• Open-ended cylinders preferred over pointed cones (pointed cones scatter more)

• Step-up (high voltage) transformer: Increases voltage to 60-90 kVp needed to accelerate electrons
• Step-down (low voltage) transformer: Provides low voltage (3-10V) to heat the filament
• kVp (kilovoltage peak) controls the energy/penetrating power of X-rays (quality of beam)

• An aluminium or leaded glass port window through which the X-ray beam exits
• The rest of the tubehead is heavily shielded

---

DIAGRAM OF X-RAY TUBEHEAD

         TUBEHEAD HOUSING (Lead-lined metal)
    ┌─────────────────────────────────────────┐
    │   [TRANSFORMER ASSEMBLY]                │
    │                                         │
    │    X-RAY TUBE (Vacuum glass envelope)   │
    │  ┌──────────────────────────────────┐   │
    │  │  CATHODE          ANODE          │   │
    │  │  [Filament]───e⁻→[Target/Focal  │   │
    │  │  [Focusing cup]    spot]         │   │
    │  │                  (Tungsten on Cu)│   │
    │  └──────────────────────────────────┘   │
    │         ↓ X-rays produced               │
    │   [ALUMINIUM FILTER]  (beam hardening)  │
    │         ↓                               │
    │   [LEAD COLLIMATOR]  (beam restriction) │
    └──────────────────────────┬──────────────┘
                               ↓
                    [POSITION INDICATING DEVICE]
                               ↓
                          PATIENT

---

PRODUCTION OF X-RAYS

---

Mechanism 1: BREMSSTRAHLUNG RADIATION (Braking Radiation)

• Accounts for ~70-80% of the X-ray output in dental radiography
• Electrons from the cathode travel at high speed toward the anode
• An electron passes close to the nucleus of a tungsten atom
• The positively charged nucleus attracts the electron, causing it to decelerate and change direction
• The kinetic energy lost during deceleration is released as an X-ray photon
• Energy of the photon = energy lost by the electron
• Electrons losing varying amounts of energy produce X-rays of varying wavelengths (polychromatic beam)
• An electron can lose all its energy in one interaction (maximum energy = kVp) producing the shortest wavelength X-ray

---

Mechanism 2: CHARACTERISTIC RADIATION

• Accounts for ~20-30% of the X-ray output
• A high-speed electron strikes and ejects an inner shell electron (e.g., K-shell) of the tungsten atom
• This creates a vacancy (electron hole) in the inner shell
• An outer shell electron drops inward to fill the vacancy
• This transition releases energy as an X-ray photon of specific, characteristic energy
• The photon energy = difference in binding energies between the two shells

---

FACTORS CONTROLLING X-RAY PRODUCTION

---

PROPERTIES OF X-RAYS

1. Invisible, travel at speed of light (3×10⁸ m/s)
2. Travel in straight lines (cannot be focused by lenses)
3. Polyenergetic (polychromatic) beam from dental tubes
4. Cause ionization of matter
5. Cause fluorescence of certain substances
6. Can expose photographic film
7. Penetrate matter (degree depends on atomic number and density of object)
8. Biological effects: cell damage, mutation, carcinogenesis

---

---

SECTION II: SHORT ANSWER QUESTIONS (8 × 4 = 32 marks)

---

Q3. Oral Manifestations of Diabetes Mellitus. Write about Oral Glucose Tolerance Test.

ORAL MANIFESTATIONS OF DIABETES MELLITUS

• Most significant and well-established oral manifestation
• Diabetes is a major risk factor for periodontitis (bidirectional relationship)
• Rapidly progressive, severe periodontitis even in young patients
• Reduced neutrophil chemotaxis, impaired healing, altered collagen metabolism
• Poor glycemic control worsens periodontitis; treating periodontitis can improve HbA1c

• Reduced salivary flow (hyposalivation)
• Due to dehydration, autonomic neuropathy affecting salivary glands, polyuria
• Leads to: difficulty chewing/swallowing, altered taste, halitosis

• Increased salivary glucose concentration
• Altered salivary pH (more acidic)
• Reduced salivary IgA
• Parotid gland enlargement (sialadenosis/sialosis) due to fatty infiltration

• Very common - elevated salivary glucose promotes Candida overgrowth
• Presentations: pseudomembranous candidiasis, erythematous candidiasis, angular cheilitis, denture stomatitis
• Particularly common in denture wearers

• Burning sensation of tongue and oral mucosa
• Associated with neuropathy, xerostomia, candidiasis

• Ageusia/dysgeusia due to neuropathy and xerostomia

• Increased caries risk due to xerostomia, elevated salivary glucose, reduced buffering capacity
• Reduced salivary flow decreases self-cleansing

• Post-extraction sockets heal slowly
• Increased risk of dry socket (alveolar osteitis)
• Increased risk of infections following dental procedures

• Higher prevalence of erosive lichen planus in diabetics

• In uncontrolled or ketoacidotic diabetes

• Facial pain, burning, paresthesia

---

ORAL GLUCOSE TOLERANCE TEST (OGTT)

• Screening for diabetes mellitus, pre-diabetes, and gestational diabetes
• When fasting glucose is borderline (6.1-6.9 mmol/L)
• Diagnosis of impaired glucose tolerance
• Relevant in oral medicine - used when diabetic background is suspected in a patient with severe periodontitis, repeated candidiasis, poor healing

• 3 days of unrestricted carbohydrate diet (>150g/day)
• Fast for 8-14 hours overnight (water permitted)
• No exercise, smoking, or medication on test morning
• Test performed in the morning

1. Fasting blood glucose measured (baseline)
2. Patient drinks 75g anhydrous glucose dissolved in 250-300 mL water (over 5 minutes)
3. For gestational diabetes: 100g glucose load
4. Blood glucose measured at 1 hour and 2 hours post-load
5. (In some protocols: 30, 60, 90, 120 minutes)

---

Q4. Drug-Induced Gingival Enlargement

CAUSATIVE DRUGS (Three main categories):

PATHOGENESIS:

• These drugs affect calcium ion channels in gingival fibroblasts
• Leads to decreased collagen degradation (reduced collagenase activity)
• Results in accumulation of collagen in the connective tissue
• Poor oral hygiene and plaque worsen the enlargement
• Genetic susceptibility plays a role (HLA typing)
• Direct drug action on gingival fibroblasts → increased fibroblastic proliferation and collagen synthesis

CLINICAL FEATURES:

• Begins as painless, firm enlargement of the interdental papillae
• Progresses to cover the crowns of teeth (may obscure them completely)
• Typically starts in the anterior teeth (especially maxillary and mandibular incisors)
• Enlargement is diffuse, lobulated, and pink (firmer than inflammatory tissue)
• Bleeds on probing if secondary inflammation is present
• Edentulous areas are NOT affected (drug effect requires tooth/plaque)
• Phenytoin: firm, fibrous, pale pink tissue; not dependent on plaque
• Cyclosporine: more vascular, softer, more hemorrhagic
• Nifedipine: similar to phenytoin but less dense

HISTOPATHOLOGY:

• Hyperplastic stratified squamous epithelium with elongated rete ridges
• Dense fibrous connective tissue with abundant collagen bundles
• Increased fibroblasts
• Variable inflammatory infiltrate depending on oral hygiene

MANAGEMENT:

1. Drug substitution: Replace offending drug if medically feasible (e.g., phenytoin → valproate; nifedipine → amlodipine → then another class)
2. Improved oral hygiene: Scaling, root planing, professional cleaning - often causes regression in mild cases
3. Chlorhexidine rinses (0.2%): Reduce plaque and inflammation
4. Surgical removal: Gingivectomy or periodontal flap surgery for severe cases
5. Folic acid supplementation (reduces phenytoin-induced enlargement)
6. Prevention: Baseline dental review before starting these drugs; meticulous oral hygiene throughout

---

Q5. Bite Marks

DEFINITION:

CLASSIFICATION:

1. Inhibited bite - Tooth contact but no break in skin
2. Contusion - Hemorrhage/bruising without skin break
3. Abrasion - Superficial scraping of skin
4. Laceration - Tearing of skin
5. Incision - Clean cut through skin
6. Avulsion - Tissue torn away

• Human bite marks: Oval/elliptical, paired arches (maxillary and mandibular), ~4-5 cm in greatest dimension
• Animal bite marks: Usually show single deep puncture wounds from canines, often with tissue avulsion

SITES IN ASSAULT/ABUSE CASES:

• Breast, shoulder, upper arm, thigh, buttocks (sexual assault)
• Cheeks, neck (child abuse)
• Defensive bite marks: knuckles, hands

CHARACTERISTICS OF HUMAN BITE MARK:

• Two opposing arched patterns (U-shaped)
• Each arch ~2-3 cm in radius
• Shows individual tooth marks within the arches
• Maxillary: broader, more rounded
• Mandibular: narrower, more square
• May show suck marks (central area of bruising) in sexual assault

FORENSIC ANALYSIS:

1. Documentation: Photography (standard scale, UV photography, 3D imaging)
2. Swabbing: DNA from saliva on bite mark (within 24-48 hours)
3. Impression: Bite mark cast
4. Comparison: Dental stone models of suspect's teeth compared with bite mark patterns
5. Overlay method: Transparent overlay of suspect's dental arch compared to bite mark

SIGNIFICANCE IN ORAL MEDICINE:

• Bite marks may present as traumatic ulcers (self-inflicted biting in seizures, or habitual cheek biting)
• Morsicatio buccarum (cheek biting): White, irregular, shredded appearance of buccal mucosa
• Must be differentiated from leukoplakia and other white lesions

---

Q6. What is a Grid? Write in Detail About Types of Grids.

DEFINITION:

WHY IS A GRID NEEDED?

• When X-rays interact with tissue, Compton scattering produces scattered photons that travel in all directions
• These scattered photons expose the film non-selectively, causing fog (uniform grey density), which reduces contrast
• Grids preferentially transmit the primary (useful) beam while absorbing scattered rays

GRID CONSTRUCTION:

• Composed of alternating strips of:
  • Lead (radiopaque strips): Absorb scattered radiation
  • Interspacer material (radiolucent): Aluminium, plastic, or carbon fiber - allows primary X-rays to pass
• The lead strips are oriented so the primary beam can pass through the radiolucent interspaces

GRID RATIO:

• Grid ratio = height of lead strip (h) ÷ width of interspace (D)
• Higher grid ratio = more efficient scatter removal but more primary radiation absorbed
• Common ratios: 5:1, 6:1, 8:1, 10:1, 12:1, 16:1
• Higher ratio grids require precise alignment (more critical)

GRID FREQUENCY:

• Number of lead strips per cm or inch
• Typical: 25-45 lines/cm
• Higher frequency = less grid lines visible on film

---

TYPES OF GRIDS

A. Based on Lead Strip Orientation:

• Lead strips are all parallel to each other and perpendicular to the film surface
• Simple construction
• Disadvantage: grid cut-off at periphery (edges of image cut off) because peripheral primary rays are angled and absorbed by grid
• Used for large-field radiography

• Two linear grids placed at right angles to each other
• More efficient scatter removal
• Requires very precise alignment; cannot be angled
• Not commonly used

• Lead strips are angled to match the divergence of the primary X-ray beam
• Strips converge toward a point called the convergence point or focal distance
• Must be used at the specific focal distance for which it was designed
• More efficient than parallel grids; no peripheral cut-off
• Most commonly used in diagnostic radiology

• A compromise between focused and parallel grid
• Strips angled at the periphery only

B. Based on Motion:

• Fixed in position during exposure
• Grid lines may be visible on the radiograph (grid lines artifact)
• Used in portable or low-volume settings

• Grid moves during exposure (oscillates or reciprocates)
• Blurs out the grid lines so they are not visible on the final radiograph
• Invented by Gustav Bucky (1913) and improved by Hollis Potter
• Bucky grid refers to the moving grid mechanism incorporated into the radiographic table/upright stand
• Standard in medical radiography
• Cannot be used for very short exposures (grid may not complete its movement)

C. Based on Interspacing Material:

• Spaces between lead strips filled with aluminium
• Durable, commonly used

• Carbon fiber interspacer
• Lower absorption of primary beam → lower patient dose
• Used in mammography

• Not an actual grid; the air space between the patient and the film acts as natural scatter rejection
• Useful when physical grid is not available

---

GRID PERFORMANCE MEASURES:

• Bucky factor (B): The factor by which patient exposure must be increased to compensate for X-rays absorbed by the grid (typically 2-6×)
• Contrast improvement factor (K): Ratio of contrast with grid to contrast without grid (measures grid efficiency)
• Selectivity (Σ): Ratio of primary radiation transmitted to scatter transmitted

GRIDS IN DENTAL RADIOLOGY:

• Rarely used in intraoral dental radiography (small field, lower scatter)
• Used in cephalometric and panoramic radiography (larger fields)
• Digital sensors have somewhat reduced the need for grids due to better contrast resolution

---

Q7. Oral Manifestations of Vitamin B Deficiency

• Angular cheilitis (cracks at corners of mouth): B2, B6, B12, iron deficiency, riboflavin deficiency
• Glossitis is common to almost all B vitamin deficiencies
• Hunter's/Moeller's glossitis: smooth, depapillated, erythematous tongue - B12 and folate deficiency
• Combined B12/folate deficiency → macrocytic megaloblastic anemia → pallor of oral mucosa

---

Q8. Dosimetry - Write in Detail About Types of Dosimeters

DEFINITION:

IMPORTANCE IN DENTISTRY:

• Monitors occupational radiation exposure of dental personnel
• Ensures compliance with maximum permissible dose (MPD) limits
• Legal requirement in most countries for radiation workers

---

TYPES OF DOSIMETERS

1. FILM BADGE DOSIMETER (Photographic Film Dosimeter)

• Most widely used for personnel monitoring
• Contains a small piece of dental/X-ray film in a plastic badge holder
• The badge has filters of different materials (aluminium, copper, tin, lead) at different positions
• Radiation darkens the film - optical density measured by densitometer
• Measures: X-rays, gamma rays, beta, neutrons (with different filters)
• Advantages: Permanent record, measures dose equivalent, inexpensive, reliable
• Disadvantages: Must be sent to laboratory for processing; not real-time; humidity/heat can affect it
• Worn: On chest, collar, or wrist; changed monthly
• Not worn: During dental radiography itself (it should be left at the operatory)

2. THERMOLUMINESCENT DOSIMETER (TLD)

• Contains thermoluminescent material: LiF (lithium fluoride), CaF₂, Li₂B₄O₇
• When exposed to radiation, electrons get trapped in crystal lattice energy states
• On heating (to ~220°C), trapped electrons release energy as visible light
• Amount of light = proportional to radiation dose (measured by photomultiplier)
• Advantages: Highly accurate, can be reused, small size, reads low doses, not affected by humidity, measures wide range of doses, most accurate for X-ray doses
• Disadvantages: Cannot be re-read; requires special reader; no permanent record after reading
• Gold standard for accurate dose measurement in radiation protection research
• Available as chips, rings, finger badges

3. POCKET DOSIMETER (Ionization Chamber / Pen Dosimeter)

• A direct-reading ionization chamber shaped like a fountain pen
• Contains a charged quartz fiber on a scale visible through a lens
• Ionizing radiation discharges the capacitor → fiber deflects
• Dose read directly by looking through the eyepiece
• Types:
  • Self-reading (can be read by wearer at any time)
  • Non-self-reading (requires external reader)
• Advantages: Immediate, direct reading; portable; no laboratory processing
• Disadvantages: Can discharge spontaneously (false high reading), fragile, expensive per unit, no permanent record
• Used in emergency/accident situations for real-time monitoring

4. ELECTRONIC PERSONAL DOSIMETER (EPD) / ACTIVE DOSIMETER

• Modern digital electronic device using silicon diodes or mini-ionization chambers
• Provides real-time digital display of current dose rate and cumulative dose
• Alarms can be set at dose thresholds
• Can be read instantly; data can be stored and transmitted electronically
• Advantages: Real-time reading, alarm capability, data logging, rechargeable
• Disadvantages: Expensive, can be affected by high-dose rate fields

5. OPTICALLY STIMULATED LUMINESCENCE (OSL) DOSIMETER

• Similar principle to TLD but uses laser light (not heat) to stimulate light emission
• Material: Aluminum oxide (Al₂O₃:C)
• Can be re-read multiple times (unlike TLD)
• Accurate for low doses, wide dose range
• Currently replacing film badges in many countries

6. GEIGER-MULLER (GM) COUNTER

• Not a personal dosimeter but a survey meter for area monitoring
• Cylindrical gas-filled tube; radiation ionizes the gas causing a current pulse counted as "clicks"
• Sensitive to low levels; gives real-time area dose rate
• Used for contamination surveys, not personal dosimetry

---

MAXIMUM PERMISSIBLE DOSE (MPD) / DOSE LIMITS (ICRP recommendations):

• Radiation workers: 20 mSv/year (averaged over 5 years); never exceeding 50 mSv in any single year
• Pregnant radiation workers: 1 mSv for the remainder of pregnancy
• General public: 1 mSv/year

---

Q9. Warthin's Tumor

DEFINITION:

EPIDEMIOLOGY:

• Accounts for approximately 10% of all parotid tumors
• Male preponderance (3-4:1 male-to-female; though ratio is narrowing as more women smoke)
• Most commonly occurs in fifth to seventh decade (50-70 years)
• Strongly associated with cigarette smoking (smokers have 8× higher risk)
• More prevalent in Caucasians
• Bilateral in 10% of cases (unique among salivary gland tumors) - occasionally multifocal

ETIOLOGY/PATHOGENESIS:

• Arises from ectopic salivary gland tissue entrapped in periparotid or intraparotid lymph nodes during embryogenesis
• The ductal epithelium undergoes oncocytic metaplasia and proliferates within lymphoid stroma
• Not truly a neoplasm by some definitions - may represent a developmental anomaly/hamartoma

CLINICAL FEATURES:

• Location: Exclusively in the parotid gland, usually in the tail of the parotid (posterior inferior parotid)
• Presents as a soft, cystic, compressible or fluctuant swelling
• Painless, slow-growing mass
• May have periodic variation in size (due to cystic nature with drainage)
• Skin overlying it is normal and mobile over the tumor
• Facial nerve function is normal
• Bilateral in 10% of cases - an important diagnostic clue
• Rarely undergoes malignant transformation (<1%)

HISTOPATHOLOGY:

• Inner layer: tall columnar oncocytic cells with granular eosinophilic cytoplasm (mitochondria-rich)
• Outer layer: small cuboidal/basal cells
• Epithelium forms papillary projections into cystic spaces filled with mucoid/serous material
• Prominent lymphoid stroma with germinal centers surrounding the cystic structures
• The combination of oncocytic epithelium + lymphoid stroma is pathognomonic

INVESTIGATIONS:

• FNA cytology (Fine Needle Aspiration): Shows oncocytes and lymphocytes - diagnostic
• Ultrasound: Well-circumscribed, hypoechoic, cystic mass
• CT/MRI: Well-defined, multilocular, cystic lesion in parotid tail
• Technetium-99m pertechnetate scan: Hot spot (increased uptake) - characteristic due to mitochondria-rich oncocytic cells; one of the few salivary gland tumors showing a hot spot

MANAGEMENT:

• Surgical excision - superficial parotidectomy with facial nerve preservation
• Low recurrence rate after complete excision
• Malignant transformation is extremely rare (<1%)

---

Q10. Write in Detail About Hyperparathyroidism

DEFINITION:

CLASSIFICATION:

• Autonomous PTH overproduction from the parathyroid gland itself
• Causes: Single adenoma (85%), hyperplasia (all 4 glands, 10-15%), carcinoma (<1%), MEN syndromes

• Compensatory PTH overproduction in response to chronic hypocalcemia
• Causes: Chronic kidney disease (most common), vitamin D deficiency, malabsorption, osteoporosis

• Autonomous PTH secretion developing from longstanding secondary hyperparathyroidism (even after the original stimulus is removed - e.g., after renal transplant)

---

GENERAL MANIFESTATIONS ("Bones, Stones, Groans, Moans"):

• Bones: Bone pain, pathological fractures, osteitis fibrosa cystica
• Stones: Renal calculi (nephrolithiasis) from hypercalciuria
• Groans: Abdominal pain, nausea, vomiting, constipation, pancreatitis, peptic ulcer
• Moans: Neuropsychiatric symptoms (depression, anxiety, cognitive impairment, weakness)

---

ORAL AND MAXILLOFACIAL MANIFESTATIONS

• Classic skeletal manifestation of severe/longstanding hyperparathyroidism
• PTH causes osteoclastic resorption → replacement of bone by fibrous tissue
• Jaw involvement: Loss of cortical bone, thinning of cortex

• Not true tumors - collections of osteoclasts, fibrous tissue, and hemorrhagic/hemosiderin-containing foci
• Brown color due to hemosiderin deposits
• Appear as well-defined radiolucent lesions in the jaws (and other bones)
• Can cause cortical expansion, pathological fractures
• Can occur in both primary and secondary hyperparathyroidism
• On biopsy: indistinguishable from giant cell granuloma - clinical/biochemical correlation needed

• Brown tumors histologically identical to central giant cell granuloma

• Loss of lamina dura around teeth (classic sign - normally a dense white line around roots)
• Ground-glass appearance of bone (loss of normal trabecular pattern)
• Subperiosteal bone resorption on radial aspect of middle phalanges (classic)
• Generalized osteopenia/osteoporosis of jaws
• "Salt and pepper" skull: Mixed lytic and sclerotic areas on skull radiograph
• Brown tumors appearing as well-defined unilocular or multilocular radiolucencies

• Tooth mobility (loss of supporting bone)
• Malocclusion (jaw expansion by lesions)
• Delayed eruption

• Ectopic calcification, metastatic calcification of soft tissues
• Sialolithiasis (salivary gland stones) - may be seen in chronic hypercalcemia

---

DIAGNOSIS:

• Serum calcium: elevated (>10.5 mg/dL in PHP)
• Serum PTH: elevated (key)
• Serum phosphate: low
• Urinary calcium: elevated
• ALP: elevated (bone isoenzyme)
• Imaging: DEXA scan (bone density), renal ultrasound, Tc-99m sestamibi scan (localizes adenoma)

MANAGEMENT:

• Primary: Surgical parathyroidectomy for symptomatic or high-risk patients
• Medical management for asymptomatic mild PHP: bisphosphonates, cinacalcet (calcimimetic)
• Brown tumors often regress spontaneously after PTH levels normalize post-surgery
• Secondary: treat underlying cause (CKD management, vitamin D supplementation, phosphate binders, cinacalcet)

---

---

SECTION III: VERY SHORT ANSWERS (10 × 2 = 20 marks)

---

Q11. Cervical Burnout

• Definition: A radiographic artifact that produces a false appearance of a carious lesion (radiolucency) at the cervical region of a tooth, where it narrows just below the contact point.
• Cause: The cervical region of the tooth has a reduced cross-sectional area (narrowing at the neck of the tooth), so fewer X-rays are absorbed here compared to the crown and root. This differential absorption creates an apparent radiolucency.
• The interproximal geometry at the cementoenamel junction creates a zone where the beam passes through less tooth structure.
• Clinical significance: Can be mistakenly diagnosed as cervical caries.
• Differentiation from true caries: Burnout appears consistently in the same location on every radiograph; it has smooth, regular borders; there is no cavitation visible clinically; explorer does not catch; the radiolucency disappears on different angulations.
• Prevention: Using the long-cone paralleling technique reduces cervical burnout compared to bisecting angle technique.

---

Q12. Tyre Track Effect

• Also called the "streetcar track" or "rail track" sign in dental radiology.
• Description: Bilateral radiopaque lines (stripes) running along the inner surface of the buccal cortical bone of the mandible, separated by a radiolucent stripe in between - resembling tram/tyre tracks.
• Cause: Calcification within the temporalis tendon insertion or the buccinators/buccal fat pad; however, more specifically it describes the appearance of the buccal cortex and the mylohyoid ridge or the mental foramen area producing parallel lines.
• In some contexts, tyre track effect refers to the parallel radiopaque lines seen due to the cortical plates of the mandible on panoramic/occlusal views.
• Clinical significance: A normal anatomical variant; should not be confused with pathology.
• Can also be seen in conditions causing subperiosteal new bone formation (periosteal reaction) where parallel layers of bone are laid down, producing a "onion skin" or tyre track appearance - associated with Ewing's sarcoma or osteomyelitis.

---

Q13. Radiographic Features of Periapical Cyst and Periapical Granuloma

Periapical Granuloma:

• Radiolucency at the apex of a non-vital tooth
• Usually small (< 1 cm in diameter)
• Well-defined but not necessarily corticated margin
• Round or oval radiolucency
• Continuous with the widening of periodontal ligament space
• Loss of lamina dura at the apex
• Cannot be reliably distinguished from a cyst radiographically - histology needed

Periapical Cyst (Radicular Cyst):

• Radiolucency at the apex of a non-vital tooth (same as granuloma)
• Usually larger (>1 cm, may reach several cm)
• Well-defined, corticated (sclerotic white border) radiolucency - due to reactive bone formation
• Round to ovoid shape
• May cause displacement of adjacent teeth and resorption of adjacent tooth roots
• May expand the cortical plates
• Continuous with the periodontal ligament space

Key Differences:

---

Q14. Café-au-Lait Spots

• Definition: Light brown ("coffee-with-milk" colored) macules (flat pigmented lesions) on the skin, varying in shade from light tan to dark brown.
• Size: Variable, from a few mm to several cm.
• Borders: Smooth, regular margins ("Coast of California" smooth border) in NF1; irregular ("Coast of Maine") in McCune-Albright.
• Significance:
  • Neurofibromatosis Type 1 (NF-1 / von Recklinghausen's disease): ≥6 café-au-lait spots (>5mm prepubertal, >15mm postpubertal) = diagnostic criterion; associated with neurofibromas, Lisch nodules, bone lesions, optic gliomas
  • McCune-Albright Syndrome: Large café-au-lait spots + polyostotic fibrous dysplasia + precocious puberty
  • Other conditions: Fanconi anemia, tuberous sclerosis, Gaucher disease, normal population (1-3 spots common in normal individuals)
• Oral/Dental relevance: NF-1 can cause oral neurofibromas, mandibular enlargement, widened inferior alveolar canal, absent or abnormal coronoid/condylar processes on OPG; fibrous dysplasia affects the jaws causing unilateral facial asymmetry.

---

Q15. White Sponge Nevus

• Also called: Cannon's disease, White Folded Gingivostomatitis.
• Nature: A hereditary, benign condition; autosomal dominant inheritance.
• Genetics: Mutations in keratin 4 (KRT4) or keratin 13 (KRT13) genes, which encode cytokeratins found in non-keratinized (lining) oral mucosa.
• Clinical Features:
  • Bilateral, symmetrical, white, folded/spongy, thickened plaques on the oral mucosa
  • Buccal mucosa is most commonly affected bilaterally (always bilateral and symmetric)
  • Lesions have a rough, corrugated, velvety texture
  • Painless, does not rub off (unlike candidiasis)
  • Present since childhood/birth; may fluctuate slightly
  • Can involve labial mucosa, floor of mouth, tongue
  • Other mucosal sites: nasal, esophageal, vaginal, rectal mucosa also affected
• Histopathology: Thick parakeratotic epithelium, extensive intraepithelial edema (vacuolization of spinous layer), basket-weave appearance of superficial keratinocytes, nuclear pyknosis with perinuclear eosinophilic condensation.
• No malignant potential
• Management: Reassurance; no treatment needed; tetracycline mouthwash may reduce thickness in some cases; genetic counseling.

---

Q16. Auspitz Sign

• Definition: A clinical sign in which gentle scraping of a scaly skin lesion (psoriatic plaque) with a wooden spatula or curette produces pinpoint bleeding from the dermal papillae after the scales are removed.
• Why it occurs: Psoriasis causes thinning of the suprapapillary epidermis over elongated dermal papillae (due to parakeratosis and acanthosis). Removing the scales first removes the overlying corneal layer, then the thin suprapapillary plate, exposing the dilated capillary loops in the dermal papillae which bleed as pinpoint red dots.
• Sign of: Psoriasis - highly characteristic.
• Significance in oral medicine: Psoriasis can have oral manifestations (geographic tongue/migratory glossitis is more common in psoriatic patients; rarely, psoriatic plaques on the oral mucosa); Auspitz sign is elicited on skin lesions to aid diagnosis, which then alerts the clinician to look for oral involvement.
• Auspitz sign is not present in seborrheic dermatitis (main differential of psoriasis) - important distinguishing point.

---

Q17. Antrolith and Phlebolith

ANTROLITH:

• A calcified mass (calculus) within the maxillary sinus (antrum).
• Also called rhinolith when in the nasal cavity.
• Formed by calcification around a foreign body (tooth, dental material, inspissated mucus) or de novo around a mucous plug.
• Radiographic features: Radiopaque mass within the maxillary sinus on OPG or Waters' view; may have a laminated structure.
• Symptoms: Facial pain, nasal discharge, sinusitis if large.

PHLEBOLITH:

• A calcified thrombus within a vein or vascular malformation (especially venous hemangioma).
• "Phlebos" = vein; "lithos" = stone.
• Results from dystrophic calcification of a thrombus that underwent organization.
• Radiographic features: Multiple small, round to oval radiopaque foci with a concentric laminated (onion-skin) pattern - pathognomonic.
• Typically seen in the cheek region in panoramic/lateral views, associated with venous malformations or haemangiomas.
• Location: Commonly in the masseter or buccinator region, floor of mouth, orbit, abdomen.
• Significance: Presence of phleboliths in the head and neck strongly suggests a venous malformation (low-flow vascular malformation).
• Not harmful in themselves; the underlying vascular lesion requires treatment if symptomatic.
• Differentiation: From sialoliths (in salivary duct path, Wharton's/Stensen's duct), lymph node calcifications, and calcified lymph nodes.

---

Q18. Oral Manifestations of Stevens-Johnson Syndrome

DEFINITION:

CAUSES:

• Drugs (most common): Sulfonamides (cotrimoxazole), anticonvulsants (carbamazepine, phenytoin, lamotrigine), NSAIDs (oxicam type), allopurinol, antibiotics (ampicillin, quinolones)
• Infections: Mycoplasma pneumoniae (most common infectious cause in children), HSV
• Idiopathic

ORAL MANIFESTATIONS:

1. Painful, extensive oral ulceration - covering large areas of the oral mucosa
2. Hemorrhagic crusting of the lips (pathognomonic) - bloody, thick, dark brown/black crusts on the vermilion border of lips; the lips are matted together with hemorrhagic crusts
3. Blisters and erosions on buccal mucosa, tongue, floor of mouth, palate
4. Desquamation of the oral epithelium - large areas of necrotic epithelium slough off
5. Profuse salivation (hypersalivation) due to pain
6. Difficulty eating, drinking, and swallowing (odynophagia) - patients may be unable to take oral nutrition
7. Fetor oris (bad oral odor) from necrotic tissue
8. Mucosal bleeding
9. Secondary infection by Candida or bacteria
10. Scarring if severe - can lead to restricted mouth opening, adhesions

SYSTEMIC FEATURES (for context):

• Fever, malaise (prodrome)
• Skin: target lesions, bullae, widespread epidermal necrosis, Nikolsky's sign
• Eye: conjunctivitis, corneal ulcers → possible blindness
• Genital: ulcers, urethritis
• Respiratory: bronchial epithelial sloughing → respiratory failure (TEN)

MANAGEMENT:

• Stop the causative drug immediately (single most important step)
• Hospitalization - burns unit/ICU for severe cases
• Supportive: IV fluids, nutrition (nasogastric tube if oral intake impossible), wound care
• Oral: chlorhexidine rinses, viscous lidocaine for pain, topical corticosteroids for oral ulcers, antifungals for candidiasis
• Systemic: Cyclosporine (evidence in SJS/TEN), IVIG, systemic corticosteroids (controversial)
• Ophthalmology consult (eye involvement can lead to blindness)

---

Q19. Examination of TMJ

STEPS:

• Facial symmetry (deviation, swelling, muscle hypertrophy)
• Observe the mandibular opening path (straight, deviation, deflection)
• Note any facial asymmetry suggesting condylar hyperplasia/aplasia

• Maximum mouth opening (interincisal distance): Normal = 40-50 mm
  • <35 mm = restricted opening (trismus)
• Lateral excursions: Normal = 8-12 mm each side
• Protrusion: Normal = 6-12 mm
• Note whether movement is smooth or jerky

• Place fingertips over the preauricular region (directly over the condylar head)
• Palpate bilaterally during opening, closing, and lateral movements
• Note: tenderness, clicking, crepitus (grating sound), condylar movement
• Clicking: A distinct sound - may be opening click (disc displacement with reduction), closing click, or reciprocal click
• Crepitus: Grating sensation = articular surface irregularity (osteoarthritis, perforation of disc)
• Can also palpate via the external acoustic meatus (dorsal surface of condyle)

• Stethoscope placed over the TMJ
• Listen for clicks, crepitus, and their timing (opening/closing)

• Masseter: Bimanually palpated (fingers inside mouth on inner surface, thumb outside); assess tender points
• Temporalis: Palpated at temporal fossa, anterior and posterior fibers
• Medial pterygoid: Intraoral palpation on medial surface of ramus/posterior of mouth floor
• Lateral pterygoid: Cannot be palpated directly; provocation test - ask patient to resist jaw protrusion (pain = lateral pterygoid involvement)
• Sternocleidomastoid, trapezius: For referred pain in TMD

• Load test: Press up under chin while patient opens against resistance (tests joint loading)
• Distinguish arthralgia (joint pain) from myalgia (muscle pain)

• Occlusion: Assess for crossbite, deep bite, tooth wear (bruxism/attrition), missing teeth
• Midline discrepancy
• Fremitus (tooth mobility on occlusion)

• Cranial nerves V, VII, IX

• OPG (panoramic): gross condylar morphology, asymmetry
• TMJ tomography (transpharyngeal, transcranial views)
• CT scan: bony changes in detail
• MRI: soft tissue disc position and morphology (gold standard for disc displacement)

---

Q20. Duplicating X-ray Films

DEFINITION:

WHY DUPLICATE?

• To send a copy to a specialist, insurance company, referring dentist, or court while retaining the original
• To produce multiple copies for teaching, second opinions, or legal purposes
• To archive records while sending the original

DUPLICATING FILM:

• A special single-emulsion film coated on only one side (unlike regular dental film which is double-emulsion)
• Orthochromatic - sensitive to green light
• Reversal film / direct duplicating film - It is a solarization film with a characteristic reversed response:
  • Exposed to more light → becomes lighter (less dense) (opposite of normal film)
  • Exposed to less light → becomes darker
  • This reversal is essential: when placed against the original (which has dark and light areas), the duplicate accurately reproduces the same densities

EQUIPMENT NEEDED:

1. Duplicator unit (light box with ultraviolet/fluorescent light source and timer)
2. Duplicating film
3. Darkroom with appropriate safelight

PROCEDURE:

1. Go to darkroom; under safelight conditions, remove duplicating film from packet
2. Place the original radiograph on the duplicating unit's glass surface (image side up)
3. Place the emulsion side of the duplicating film (dull side) face down against the original
4. Close the lid tightly to ensure contact
5. Expose to the ultraviolet/fluorescent light for the recommended time (usually 2-10 seconds, determined by test exposures)
6. Process the duplicating film through normal developer and fixer (in standard darkroom processing)
7. The resulting duplicate is a copy with the same density and contrast as the original

KEY POINTS:

• Longer exposure time → lighter duplicate (due to solarization/reversal effect)
• Shorter exposure time → darker duplicate
• No radiation used - uses visible/UV light from the duplicator unit
• Contact is critical - any gap causes blurring of the duplicate
• Emulsion-to-emulsion contact between original film and duplicating film is essential

---

---

PERIODONTITIS

A Comprehensive Overview

---

1. DEFINITION

• Peri = around
• Odont = tooth
• Itis = inflammation

It is distinct from gingivitis, where inflammation is confined to the gingival soft tissues only, with no bone loss. Gingivitis is reversible; periodontitis is not fully reversible as lost bone and attachment do not spontaneously regenerate.

---

2. CLASSIFICATION (2017 AAP/EFP World Workshop - Current Classification)

• "Chronic periodontitis" and "Aggressive periodontitis" were merged under the single umbrella term "Periodontitis."
• A multidimensional Staging and Grading system (modelled on oncology) was introduced.

2A. TYPES OF PERIODONTAL DISEASE

• Necrotizing Ulcerative Gingivitis (NUG)
• Necrotizing Ulcerative Periodontitis (NUP)
• Necrotizing Stomatitis

• Diseases influencing the periodontal tissues (e.g., hematologic disorders, genetic disorders)

---

2B. STAGING OF PERIODONTITIS (Severity and Complexity)

---

2C. GRADING OF PERIODONTITIS (Rate of Progression and Risk)

---

3. EPIDEMIOLOGY

• Periodontitis is the most common chronic inflammatory disease in adults worldwide.
• Severe periodontitis (Stage III/IV) affects approximately 11% of the global population (~800 million people), making it the 6th most prevalent disease globally.
• It is the leading cause of tooth loss in individuals over 35-40 years.
• Prevalence increases with age.
• More common in males, smokers, and individuals with uncontrolled diabetes.
• Bidirectional relationship with systemic diseases (especially diabetes mellitus).

---

4. ETIOLOGY

Primary Etiologic Factor: Dental Plaque Biofilm

• Aggregatibacter (Actinobacillus) actinomycetemcomitans (Aa) - produces leukotoxin; important in aggressive/juvenile periodontitis
• Prevotella intermedia - elevated in NUG/NUP and pregnancy gingivitis
• Fusobacterium nucleatum - bridging organism in biofilm architecture

Virulence Factors of Periodontal Pathogens:

• Lipopolysaccharide (LPS) - triggers TLR-mediated immune activation
• Proteases (gingipains) of Pg - destroy collagen, immunoglobulins, complement components
• Leukotoxin of Aa - destroys neutrophils and macrophages
• Spirochete invasion (T. denticola) - direct tissue invasion
• Cross-feeding/synergism between Pg, Td and other plaque members promotes disease progression

---

5. PREDISPOSING (RISK) FACTORS

• Poor oral hygiene (primary driver)
• Calculus (supra- and sub-gingival)
• Malocclusion, crowding (reduces self-cleansing)
• Mouth breathing (gingival drying)
• Defective restorations (open margins, overhangs)
• Partial dentures (plaque retention)

• Diabetes mellitus (most important systemic risk factor; bidirectional - DM worsens periodontitis, periodontitis worsens glycemic control)
• Smoking (reduces tissue vascularity, impairs neutrophil function, masks bleeding on probing, single most important modifiable risk factor in HIV-negative patients)
• HIV infection/immunosuppression
• Medications: Calcium channel blockers, cyclosporine, phenytoin (drug-induced gingival overgrowth → more plaque retention)
• Hormonal changes: Pregnancy, puberty, oral contraceptives (increase vascular permeability and gingival response to plaque)
• Nutritional deficiencies: Vitamin C deficiency (scurvy) → severe gingival and periodontal breakdown
• Stress: Associated with NUP and worsening of chronic periodontitis
• Genetic susceptibility (IL-1 gene polymorphisms linked to increased susceptibility)

---

6. PATHOGENESIS

Stage 1 - Initial Lesion (0-4 days of plaque accumulation):

• Acute vascular response
• Increased gingival crevicular fluid flow
• Predominantly PMN (neutrophil) infiltration
• No clinical signs except slight erythema

Stage 2 - Early Lesion (4-7 days):

• More vascularity, capillary proliferation
• Lymphocytic infiltrate predominates
• Collagen destruction begins
• Early gingivitis clinically apparent (redness, bleeding on probing)

Stage 3 - Established Lesion (weeks-months):

• Dense plasma cell and lymphocyte infiltrate
• Significant collagen loss
• Pocket epithelium proliferates downward
• Clinical gingivitis - but reversible at this stage

Stage 4 - Advanced Lesion (months-years) = PERIODONTITIS:

• Plasma cells dominate
• Alveolar bone resorption begins (osteoclastic activity driven by cytokine cascade)
• Key cytokines driving bone loss: IL-1β, TNF-α, PGE₂, RANKL
• Junctional epithelium migrates apically → true periodontal pocket formation
• Loss of clinical attachment (CAL)
• Progressive destruction if untreated → tooth mobility → tooth loss

Mechanisms of Bone Destruction:

• Bacterial LPS activates macrophages → release of IL-1β, TNF-α → stimulate fibroblasts and osteoblasts to release RANKL
• RANKL (Receptor Activator of NF-κB Ligand) activates osteoclasts → bone resorption
• This is the same pathway exploited by the drug denosumab (anti-RANKL) in osteoporosis

---

7. CLINICAL FEATURES

Signs and Symptoms:

• Redness and color change (from coral pink to red/purplish-red)
• Swelling and loss of normal knife-edge gingival contour
• Bleeding on probing (BOP) - cardinal sign; indicates active inflammation
• Spontaneous bleeding in severe cases
• Gingival recession (in some patients, gingiva recedes rather than pocketing)
• Pus discharge from pockets (suppuration)
• Bad breath (halitosis) - due to volatile sulfur compounds from anaerobic bacteria

• True periodontal pocket: apical migration of junctional epithelium with bone loss
• Probing depth > 3 mm = abnormal
• Pocket measured by WHO probe or UNC-15 probe

• Horizontal bone loss (most common type - uniform crestal bone loss)
• Vertical/angular bone loss (creates infrabony pockets - indicates more aggressive disease)
• Furcation involvement in multi-rooted teeth

• Tooth mobility (grades I, II, III)
• Pathological migration/drifting of teeth
• Spacing between teeth (diastemata) due to bone loss and tongue pressure
• Sensitivity to hot/cold due to root exposure
• Food impaction in interdental areas

• Bleeding gums (often first symptom patient notices)
• Pain unusual unless acute exacerbation or abscess
• Loose teeth
• Bad taste in mouth

---

8. TYPES IN DETAIL

8A. Chronic Periodontitis (now just "Periodontitis" in 2017 classification)

• Most prevalent form
• Affects adults >35 years
• Slow to moderate progression
• Amount of destruction consistent with local factors
• Associated with subgingival calculus

8B. Necrotizing Ulcerative Periodontitis (NUP)

• Distinct clinicopathological entity
• Acute onset, extremely painful - unlike ordinary periodontitis
• Punched-out, crater-like destruction of interdental papillae with overlying grey necrotic pseudomembrane
• Characteristic fetid odor (halitosis)
• Systemic features: fever, malaise, regional lymphadenopathy
• Rapid destruction of interdental bone creating "reverse architecture"
• Etiology: Fusospirochetal infection (Fusobacterium, spirochetes, Prevotella intermedia)
• Risk factors: HIV/AIDS, severe immunocompromise, malnutrition, stress, poor oral hygiene, smoking
• In HIV patients: can progress to severe NUP with exposure of alveolar bone and sequestration
• Treatment: Debridement + metronidazole 250 mg TID for 7 days + chlorhexidine rinses + pain control

8C. Localized Aggressive Periodontitis (now Stage III/IV, Grade C - Molar-Incisor pattern)

• Previously "Localized Juvenile Periodontitis"
• Affects adolescents and young adults
• Classic pattern: First molars and central incisors (6s and 1s)
• Rapid bone loss ("arc-shaped" bone loss on radiograph around first molars)
• Amount of destruction disproportionate to plaque levels (little plaque, severe bone loss)
• Associated with A. actinomycetemcomitans (leukotoxin impairs neutrophil response)
• Family history positive (autosomal dominant with incomplete penetrance)

8D. Generalized Aggressive Periodontitis (now Stage III/IV, Grade C - Generalized)

• Generalized interproximal attachment loss involving ≥3 teeth other than first molars and incisors
• Affects young adults (<30 years typically)
• Rapid progression
• Episodic bursts of disease activity

---

9. PERIODONTAL EXAMINATION

• Color, contour, consistency, texture
• Presence of bleeding on probing (BOP score - %)
• Presence of suppuration

• 6-point probing per tooth (DB, B, MB, DL, L, ML)
• Probing depth (PD): Gingival margin to base of pocket
• Clinical Attachment Level (CAL): CEJ to base of pocket = PD ± recession
• Normal probing depth: 1-3 mm

• Periapical radiographs (gold standard for individual tooth assessment)
• Bitewing radiographs (for posterior interproximal bone levels)
• OPG (panoramic view) - screening, full arch overview
• CBCT - for advanced cases, implant planning, bone defect morphology

• Loss of alveolar crest height (normal: within 1-2 mm of CEJ)
• Widening of periodontal ligament space
• Loss of lamina dura
• Horizontal and vertical bone loss patterns
• Furcation involvement (triangular radiolucency at furcation area)

• Class I: Barely perceptible movement (<0.2 mm horizontal)
• Class II: Perceptible movement (0.2-1 mm horizontal)
• Class III: Movement >1 mm horizontal OR vertical (depressible)

• Class I: Probe enters <3 mm horizontally
• Class II: Probe enters ≥3 mm but does not pass through
• Class III: Probe passes through furcation (through-and-through)

---

10. SYSTEMIC ASSOCIATIONS

---

11. MANAGEMENT

STEP 1: Patient Education and Risk Factor Modification

• Oral hygiene instruction (OHI): Correct brushing technique (Modified Bass method), interdental cleaning (floss, interdental brushes)
• Smoking cessation counseling
• Diabetes management (coordinate with physician; target HbA1c <7%)
• Nutritional counseling

---

STEP 2: Cause-Related Therapy (Supragingival and Subgingival Debridement)

• Supragingival scaling: Removal of calculus and plaque above the gingival margin
• Subgingival scaling and root planing (deep scaling): Mechanical debridement of subgingival calculus, disruption of biofilm, and removal of toxin-impregnated cementum
• Performed with: Hand instruments (Gracey curettes, scalers) + Ultrasonic/sonic scalers
• Single visit full-mouth debridement (FMD) vs. quadrant-by-quadrant
• Re-evaluation at 4-8 weeks post SRP to assess treatment response

• Tetracycline fibers, chlorhexidine chips, minocycline microspheres, doxycycline gel - placed directly into periodontal pockets
• Used as adjuncts to SRP in localized deep pockets (≥5 mm) that do not respond to SRP alone

• Reserved for aggressive/refractory periodontitis, NUP, medically compromised patients

• Chlorhexidine gluconate (0.12-0.2%) mouth rinse - preferred antiseptic rinse; 2× daily; effective against plaque and gingivitis; not a long-term substitute for mechanical cleaning
• Povidone-iodine irrigation (subgingival)

---

STEP 3: Re-evaluation (4-8 Weeks Post-SRP)

• Assess response: BOP score, probing depths, CAL
• If pockets ≤4 mm → periodontal maintenance
• If pockets ≥5-6 mm persist → consider surgical intervention

---

STEP 4: Periodontal Surgery (For Non-Responding Cases)

• Gingivectomy - for fibrous suprabony pockets
• Flap surgery (Modified Widman Flap, apically repositioned flap) - to access deeper root surfaces

• Guided Tissue Regeneration (GTR) - membrane barriers to exclude epithelium, allow periodontal ligament and bone to regenerate
• Bone grafts: Autografts, allografts, xenografts, alloplasts
• Enamel Matrix Derivative (Emdogain® - amelogenin proteins) - promotes PDL and bone regeneration
• Growth factors (PDGF, FGF)

• Free gingival graft, connective tissue graft - for root coverage in recession defects

---

STEP 5: Maintenance (Supportive Periodontal Therapy - SPT)

• Every 3 months for active periodontitis; 6 months for stable cases
• Professional scaling, review OHI, reassess probing depths
• Life-long commitment required as periodontitis cannot be "cured," only controlled

---

12. PERIODONTAL ABSCESS

• Gingival abscess (within gingival tissues only)
• Periodontal abscess (in the periodontal pocket wall)
• Pericoronal abscess (around a partially erupted tooth)

• Acute onset swelling, throbbing pain, tenderness on percussion
• Suppuration/pus discharge from pocket
• Tooth mobile and tender
• Regional lymphadenopathy, fever in severe cases

• Drainage (through the pocket or incision and drainage if fluctuant)
• Scaling/debridement once acute phase resolves
• Antibiotics if systemic involvement: Amoxicillin 500 mg TID or Metronidazole 400 mg TID × 5-7 days
• Analgesics: Ibuprofen 400-600 mg QID

---

13. RADIOGRAPHIC FEATURES OF PERIODONTITIS

---

14. SUMMARY TABLE

---

ATHEROSCLEROSIS

A Comprehensive Review

---

1. DEFINITION

• Athero (Greek: gruel/porridge) - refers to the soft lipid core
• Sclerosis (Greek: hardening) - refers to the fibrous component

It is the single most important disease in the Western world, responsible for roughly half of all deaths and the underlying cause of coronary artery disease, stroke, and peripheral vascular disease.

• Robbins & Cotran Pathologic Basis of Disease

---

2. ARTERIOSCLEROSIS vs ATHEROSCLEROSIS

---

3. EPIDEMIOLOGY

• Most common cause of morbidity and mortality in Western nations
• Myocardial infarction alone accounts for ~25% of all deaths in the USA
• Death rates from coronary artery disease in Eastern Europe are 3-5× higher than the USA, and 7-12× higher than Japan
• Africa, India, and Southeast Asia now have death rates from coronary artery disease exceeding that of the USA, driven by urbanization and Western diet adoption
• Risk identified through landmark Framingham Heart Study (prospective cohort study)

---

4. RISK FACTORS

4A. NON-MODIFIABLE (Constitutional) Risk Factors

4B. MODIFIABLE Risk Factors

4C. Additional / "Novel" Risk Factors

• Obesity (especially abdominal/visceral adiposity)
• Physical inactivity
• Metabolic syndrome (insulin resistance, central obesity, dyslipidemia, hypertension)
• Lipoprotein(a) - elevated levels are an independent risk factor
• Homocysteinemia - damages endothelium; thrombogenic
• Chlamydia pneumoniae infection (controversial)
• Chronic kidney disease
• Sleep apnea
• Stress / Type A personality

---

5. PATHOGENESIS - "Response to Endothelial Injury" Hypothesis

STEP-BY-STEP SEQUENCE:

Step 1 - Endothelial Injury and Dysfunction

• The initiating event is injury to the vascular endothelium (EC)
• Causes of endothelial injury/dysfunction:
  • Hemodynamic disturbance (turbulent flow, especially at branch points and curvatures)
  • Oxidized LDL lipoproteins
  • Cigarette smoke toxins
  • Hypertension (mechanical shear stress)
  • Elevated homocysteine
  • Infectious agents (CMV, Chlamydia)
  • Inflammatory cytokines
• Injured ECs: reduce nitric oxide (NO) production (loss of vasodilator and anti-adhesion function); increase expression of adhesion molecules (VCAM-1, ICAM-1, E-selectin)

Step 2 - Monocyte Adhesion and Migration (Formation of Fatty Streak)

• Circulating monocytes and LDL accumulate at the site of endothelial injury
• Monocytes adhere to the activated endothelium via VCAM-1 and other adhesion molecules
• Monocytes cross the endothelium and enter the intima
• In the intima, monocytes differentiate into macrophages
• Macrophages ingest and oxidize accumulated LDL via scavenger receptors → become foam cells (lipid-laden macrophages with foamy appearance due to lipid droplets)
• Accumulation of foam cells produces the first visible lesion: the fatty streak

Step 3 - Inflammation and Cytokine Release

• Foam cells and activated ECs release:
  • IL-1β, TNF-α → recruit more monocytes/macrophages, T lymphocytes
  • Chemokines (MCP-1) → attract more monocytes
  • Growth factors (PDGF, FGF) → stimulate smooth muscle cell (SMC) migration and proliferation
• T lymphocytes are also recruited → release IFN-γ → activates macrophages and ECs further
• Cholesterol crystals activate the NLRP3 inflammasome → IL-1β production (major atherogenic cytokine)
• Oxidized LDL is also directly cytotoxic to ECs and SMCs
• This self-amplifying inflammatory cycle drives progressive lesion formation

Step 4 - Smooth Muscle Cell (SMC) Migration and Proliferation

• Growth factors (PDGF from platelets and macrophages, FGF, TGF-β) stimulate SMC migration from the media to the intima
• SMCs undergo a phenotypic change: from contractile (normal medial SMC) to synthetic (proliferative) phenotype
• Intimal SMCs proliferate and synthesize ECM (collagen, proteoglycans, elastin) in a process analogous to wound healing
• This converts the early fatty streak into a more organized fibrous lesion - the atherosclerotic plaque

Step 5 - Plaque Formation and Growth

• The mature atherosclerotic plaque (atheroma) consists of:
  • Fibrous cap (surface layer of SMCs, dense collagen, proteoglycans)
  • Atheromatous core (necrotic center with lipid debris, cholesterol crystals, dead foam cells, calcifications)
  • Shoulder regions - more cellular, with SMCs, macrophages, T lymphocytes
• The plaque grows eccentrically into the lumen
• Initially, outward (positive) remodeling compensates (Glagov phenomenon) - lumen is preserved until ~40% of vessel wall is involved
• Eventually, the plaque encroaches on the lumen, reducing blood flow

---

6. MORPHOLOGY OF LESIONS (Stages)

Stage 1 - Fatty Streak

• Earliest lesion - can begin in aortas of infants and virtually all adolescents
• Gross: Small, flat, yellow macules that coalesce into streaks 1 cm or longer
• Slightly raised; do NOT obstruct blood flow
• Microscopy: Lipid-filled foam cells (macrophages + some SMCs) in the intima
• Potentially reversible with risk factor modification
• Not all fatty streaks progress to plaques

Stage 2 - Gelatinous Lesion / Pre-atheroma

• Focal increase in smooth muscle cells and matrix in intima
• Bridge between fatty streak and fibrous plaque

Stage 3 - Fibrous (Atherosclerotic) Plaque - Established Atheroma

• Yellow-tan raised lesions on the luminal surface of arteries
• Vary in size; may coalesce into large masses
• Eccentric lesions (occupy only a portion of vessel wall circumference)
• Superimposed thrombus appears red-brown

1. Lower abdominal aorta and iliac arteries (most severely involved)
2. Coronary arteries
3. Popliteal arteries
4. Internal carotid arteries
5. Vessels of the circle of Willis

• Upper extremity vessels, mesenteric, and renal arteries (except ostia) relatively spared

1. Cells: SMCs, macrophages (foam cells), T lymphocytes
2. Extracellular matrix: Collagen, elastic fibers, proteoglycans
3. Intracellular and extracellular lipids: Cholesterol crystals, cholesterol esters
4. Calcifications: In advanced/late-stage plaques

• Fibrous cap (superficial): Dense collagen synthesized by SMCs; provides structural integrity
• Atheromatous/necrotic core (deep): Soft, grumous lipid material, cholesterol crystals, necrotic debris, dead foam cells
• Shoulder regions (lateral to cap): More cellular; more vulnerable to rupture

Stage 4 - Complicated Plaque

1. Calcification - dystrophic calcification of dead cells and lipids → hardening of arteries
2. Ulceration/Erosion - loss of fibrous cap surface
3. Thrombosis - superimposed thrombus on ulcerated/eroded plaque → acute occlusion
4. Hemorrhage into plaque - rupture of intraplaque neovessels (vasa vasorum) → sudden plaque expansion
5. Aneurysm formation - plaque thickening impedes oxygen diffusion to media → medial ischemia and weakening

---

7. STABLE vs. VULNERABLE (UNSTABLE) PLAQUES

Mechanisms of Plaque Rupture:

• Activated macrophages in the vulnerable plaque produce metalloproteinases (MMPs) → degrade collagen in the fibrous cap → thin, weaken the cap
• Reduced collagen synthesis by dying SMCs further weakens the cap
• IFN-γ from T cells inhibits SMC collagen synthesis
• Physical stresses: blood pressure spikes, adrenergic surges (circadian peak: 6 AM-12 noon - explains morning peak of MI)

---

8. CONSEQUENCES / COMPLICATIONS

8A. Coronary Artery Disease (IHD)

• Stable angina pectoris: Gradual luminal narrowing (>70%) → effort-induced ischemia (fixed obstruction)
• Unstable angina: Plaque rupture with non-occlusive thrombus → rest pain
• Myocardial infarction: Plaque rupture + complete occlusive thrombus → transmural infarction (STEMI) or subendocardial infarction (NSTEMI)
• Sudden cardiac death: Plaque rupture + ventricular arrhythmia

8B. Cerebrovascular Disease

• Ischemic stroke / TIA: Carotid artery plaque → embolization → cerebral infarction
• Multi-infarct dementia: Repeated small emboli

8C. Peripheral Vascular Disease

• Lower extremity arterial disease → claudication, rest pain, ischemic ulcers, gangrene
• Renovascular disease → renal artery stenosis → secondary hypertension

8D. Aortic Aneurysm

• Atherosclerosis of aorta → medial ischemia and weakening → aneurysm (especially abdominal aortic aneurysm, below the renal arteries)
• Risk of rupture → catastrophic hemorrhage
• Aneurysm types:
  • Saccular: Discrete spherical outpouching
  • Fusiform: Circumferential dilation

8E. Mesenteric Ischemia

• Celiac/SMA/IMA involvement → bowel ischemia

---

9. BIOCHEMICAL MECHANISMS IN DETAIL

Role of LDL and Oxidized LDL:

• Native LDL enters the subendothelial space → becomes oxidized LDL (oxLDL) by ROS from macrophages/ECs
• OxLDL is taken up by macrophage scavenger receptors (SR-A, CD36) (unlike normal LDL receptor, scavenger receptors are NOT down-regulated by intracellular cholesterol accumulation → unlimited uptake → foam cell formation)
• OxLDL effects:
  • Cytotoxic to ECs and SMCs
  • Promotes monocyte recruitment (upregulates MCP-1)
  • Stimulates growth factor and cytokine release
  • Pro-thrombotic (reduces thrombomodulin)

Role of HDL (Protective):

• HDL mediates reverse cholesterol transport - removes cholesterol from foam cells/peripheral tissues → liver for catabolism
• HDL also has anti-oxidant and anti-inflammatory properties

Cholesterol Crystals and Inflammasome:

• Cholesterol crystals accumulate in macrophage lysosomes → lysosomal damage → activates NLRP3 inflammasome → caspase-1 activation → IL-1β and IL-18 secretion → amplified inflammation

---

10. HISTOPATHOLOGY SUMMARY

---

11. PREVENTION AND TREATMENT

Primary Prevention (Risk Factor Modification):

• Lipid lowering: Statins (HMG-CoA reductase inhibitors) - first line; reduce LDL, stabilize plaques (anti-inflammatory, reduce plaque macrophage content), prevent cardiovascular events
• Blood pressure control: Target <130/80 mmHg; ACE inhibitors, ARBs, CCBs
• Smoking cessation
• Glycemic control in diabetes: Target HbA1c <7%
• Exercise: 150 min/week moderate aerobic activity
• Diet: Mediterranean diet; reduce saturated fats, trans fats; increase soluble fiber, omega-3 fatty acids
• Aspirin (low-dose 75-100 mg): Anti-platelet for secondary prevention (not recommended for primary prevention routinely due to bleeding risk)

Pharmacotherapy:

Interventional / Surgical:

• Percutaneous Coronary Intervention (PCI): Balloon angioplasty + drug-eluting stent placement
• Coronary Artery Bypass Grafting (CABG): For multi-vessel or left main disease
• Carotid endarterectomy: For symptomatic high-grade carotid stenosis
• Peripheral vascular interventions: Angioplasty, bypass grafts for limb ischemia

---

12. KEY MOLECULAR MEDIATORS SUMMARY

---

13. SUMMARY TABLE

1. Vesiculobullous & ulcerative lesions - Pemphigus vulgaris, Pemphigoid, Erythema multiforme, Aphthous ulcers, Herpes simplex/zoster, Stevens-Johnson syndrome, ANUG
2. White/red lesions & potentially malignant disorders - Lichen planus, Leukoplakia, OSMF, Candidiasis, Erythroplakia
3. Orofacial pain - Trigeminal neuralgia, MPDS/TMD, Atypical facial pain, Trismus, Eagle's syndrome
4. Salivary gland disorders - Sjogren's syndrome, Sialadenitis, Sialolithiasis, Mucocele, Pleomorphic adenoma, Xerostomia
5. Oral manifestations of systemic disease - Anemia, Hemophilia/bleeding disorders, Leukemia, Diabetes, HIV/AIDS, Renal failure, Cardiac patient dental management, Hyperparathyroidism, Syphilis
6. Cysts, tumors & bone lesions - Dentigerous cyst, OKC, Ameloblastoma, Periapical cyst/granuloma, Paget's disease, Fibrous dysplasia, Cherubism, Osteosarcoma, Osteomyelitis
7. Pigmentation & genetic/developmental conditions - Café-au-lait spots, Peutz-Jeghers, Albright's syndrome, Gardner's syndrome, Ectodermal dysplasia, Gorlin-Goltz, Cleidocranial dysostosis

1. One specific year's full paper - tell me which year/session (e.g. "April 2025" or "January 2018")
2. Vesiculobullous & ulcerative lesions cluster - Pemphigus, Pemphigoid, Erythema multiforme, Aphthous ulcers, Herpes, Stevens-Johnson, ANUG
3. Orofacial pain cluster - Trigeminal neuralgia, MPDS/TMD, Trismus, Atypical facial pain, Eagle's syndrome
4. X-ray physics, production & radiographic techniques cluster - X-ray tube/production, IOPA techniques, panoramic, occlusal, bitewing, extraoral views
5. Radiation biology, hazards & protection cluster - cell/tissue radiosensitivity, dosimetry, ALARA, radiation effects
6. Oral manifestations of systemic disease cluster - Anemia, Hemophilia, Leukemia, Diabetes, HIV/AIDS, Renal failure, cardiac patient management
7. Cysts, tumors & bone lesions cluster - Dentigerous cyst, OKC, Ameloblastoma, Paget's disease, Fibrous dysplasia, Cherubism, Osteosarcoma
8. Forensic odontology cluster - Bite marks, lip prints, age/sex determination, wound certificates